MBA Program in
Health Care Management
2020
RESUME
BOOK
Wharton
Contents
Program Description .......................4
Curriculum ...............................5
Graduates ............................6-29
Internship Sponsors....................30-31
Health Care Program Mentors ...........32-36
Administration ..........................37
Faculty ..............................38-39
Thank you for your interest in the Wharton MBA Program
in Health Care Management. For further information,
resumes, and appointments, contact:
June Kinney, Associate Director,
MBA Program in Health Care Management
The Wharton School
University of Pennsylvania
3641 Locust Walk
Philadelphia, PA 19104-6218
215.898.6861
email: [email protected]
For information on the Wharton Health
Care Management Alumni Association, visit
www.whartonhealthcare.org
For detailed information on the Health Care
Management Department educational programs,
visit http://mba.wharton.upenn.edu/healthcare
MBA Graduates
The University of Pennsylvania was founded by
Benjamin Franklin in 1740. Although the University
carries the name of the Commonwealth, it is not
a state university but an independent, private,
nonsectarian institution. As one of the country’s
earliest educational institutions, it has consistently
initiated advances in teaching and research and
has steadily generated specialized fields of higher
education. Penn, as the University is commonly
known, was the first American university to form
departments of botany, hygiene and public health,
surgical research, and research medicine. The
University School of Medicine, formed in 1765,
was the first in North America, as was the teaching
hospital founded in 1874. The world’s first
psychological clinic was opened at Penn in 1896.
The Wharton School, in the same spirit of
innovation and excellence, was the world’s first
collegiate school of business and management.
Founded in 1881 with a gift from Joseph Wharton,
the Philadelphia industrialist and philanthropist,
the Wharton School undertook the pioneer steps
in elevating training for business significantly
above its previous level as noncollegiate commercial
education. In 1921, the formation of the Graduate
Program signaled the advancement of business
administration at Wharton to the highest levels
of professional education.
Today, the Wharton School has more than 480
faculty members teaching in both the graduate
and undergraduate divisions and conducting a
continually expanding volume of research. The
1,785 students in the master’s degree program
may choose from among more than 200 courses
and over 19 majors and concentrations, a variety
reflecting the fact that the Wharton education
complements the career goals of the individual.
This brochure is provided to introduce you to
the 2020 Wharton Health Care Management
Program graduates.
We encourage you to consider these individuals
for employment.
2020
Health Care Management
3
4
The Graduate Program in Health Care Management
is a full-time 2-year MBA curriculum offered
by the Health Care Management Department of
the Wharton School. The program, the principal
educational effort at the Leonard Davis Institute
of Health Economics, is designed to provide
managerial and technical expertise to students
interested in the health care management field.
By combining the skills of the Wharton disciplines
with sensitivity to the needs of health care providers
and recipients, the Wharton MBA health care
graduate can effectively manage the delivery
of health services and products at all levels.
The Program has produced graduates who have
chosen careers in hospitals and other medical
institutions, pharmaceutical, biotechnology and
medical device companies, financial services,
entrepreneurial ventures, consulting firms,
insurance firms, private health industry, and
federal, state, and local government. Many
of these MBA graduates now hold positions
as chief executive officers, directors, and other
key decision makers in health care organizations.
The Leonard Davis Institute of Health Economics
(LDI) is an interdisciplinary center for research
and education in the organization, financing,
and delivery of health care. Through LDI, University
of Pennsylvania faculty and staff work together
on issues concerning health policy, health
insurance, managed care, hospitals, corporations,
pharmaceutical companies, and other health-
related organizations. Established in 1967, the
Institute appropriately bears the name of the late
Leonard Davis, one of the foremost innovators in
private health insurance in the United States. He
was the founder of Colonial Penn Group, Inc., a
company that has pioneered in insurance for older
Americans. Both Mr. Davis and Mrs. Sophie Davis
were generous benefactors to the University of
Pennsylvania, contributing basic support for the
activities of the Leonard Davis Institute.
Program Description
5
All students are required to complete the Wharton Management
Core. The Wharton School’s core curriculum is designed to
increase crossfunctional integration, extend global experience,
strengthen leadership training, and introduce new courses on
key management issues. The core curriculum provides ground-
work in basic management disciplines: economics,
finance, financial and cost accounting, management science,
managing people and organizational design, marketing,
operations management, the governmental and legal
environment of business, statistics, and strategy.
Fixed Core:
• Leadership: Foundations of Teamwork and Leadership
• Marketing: Marketing Management
• Microeconomics: Microeconomic Foundation
• Economics: Advanced Topics in Managerial Economics
• Statistics: Regression Analysis for Managers
• Management Communication: Speaking and Writing
Flexible Core:
Operations, Information, and Decisions
• Quality and Productivity
• Business Analytics
• Information Technology and Business Transformation
• Innovation
• Operations Strategy
Marketing
• Dynamic Marketing Strategy
• Strategic Marketing Simulations
Communications
• Advanced Persuasive Speaking
• Communications Challenges for Entrepreneurs
Accounting
• Financial Accounting
• Accelerated Financial Accounting
• Financial and Managerial Accounting
Corporate Finance
• Corporate Finance
• Accelerated Corporate Finance
• Introduction to Corporate Finance
Macroeconomics
• Macroeconomics
• Introduction to Macroeconomics
Management
• Managing the Established Enterprise
• Managing the Emerging Enterprise
Legal Studies & Business Ethics
• Responsibility in Global Management
• Responsibility in Business
International Programs:
Global Modular Courses: Short full-credit courses in an intensive
workshop format in a country relevant to the topic.
Global Immersion Program (GIP):
A high-level survey of the economic, cultural, and geo-political
drivers behind regions integral to the global economy. Students
then experience it in-country.
The Health Care Major Courses and Electives:
These courses promote an understanding of concepts,
institutions, and issues involved in the organization,
financing, and delivery of health services and products
in the United States. Health care electives are selected
consistent with individual career objectives and interests.
Required
• Health Services System
• Health Care Field Application Project
Electives
• Comparative Health Care Systems
• E-Health: Business Models and Impact
• Financial Management of Health Institutions
• Healthcare Data & Analytics
• Health Care Entrepreneurship
• Health Care Reform and the Future of
the American Health System
• Health Care Services Delivery:
A Managerial Economic Approach
• Managed Care and the Industrial Organization
of Health Care
• Management & Economics of Pharmaceutical,
Biotechnology, & Medical Device Industries
• Management and Strategy in Medical Devices
and Technology
• Management of Health Care for the Elderly
• Management of Health Care Service Businesses
• Managing Health Care Organizations
• Private Sector Development in Global
Health Development
• Advanced Study Project
The Health Care Summer Internship
The internship is a 3-month management experience that
provides the health care major an opportunity to work with
a senior executive in an organization of particular interest to
the student.
MBA Electives
Opportunities are available for the health care major to pursue
a second concentration in fields such as entrepreneurship,
marketing, finance, or operations, or to pursue specialized
knowledge in areas such as health care financing or within
specialized segments of the health care industry including
managed care organizations, hospitals, pharmaceutical and
biotechnology companies, medical device companies, specialty
services organizations, and long term care organizations.
Graduate courses are available throughout the University.
Curriculum
The Wharton Management Core
6
Sophie K. Alpert
Bowdoin College, Brunswick, ME
A.B., Mathematics and Economics, 2013
An opportunity to develop innovative
digital health products and drive
improved health care outcomes
Johnson & Johnson, San Francisco, CA
Partnerships and Corporate Development
Intern (Global Health Tech), Summer 2019
Developed digital strategy and
partnership recommendation for
medication adherence consisting of
an analysis of patient needs, business
case to develop an internal solution
and vendor assessment. Evaluated
100+ digital solutions to address
medication non-adherence across
different sectors, including: DTC
pharmacy, care coordination and
behavior modification apps. Created
and implemented scoring framework
and prioritization for vendor selection
based on patient needs for medication
adherence for top J&J brands.
Collective Health, San Francisco, CA
Senior Operations Specialist, 2015-2018
Led team of Operations Associates
in the creation of a new claims
classification system. Built and operated
account management database and
collaborated with engineering team
to develop product requirements for
flexible spending accounts product.
Streamlined requirements and
protocols for reinsurance reporting
and reconstructed the reporting
method.
Cowen and Company, San Francisco, CA
Investment Banking Analyst, 2013-2015
Executed capital markets and M&A
transactions for life sciences and
medical device clients. Constructed
accretion/dilution, discounted cash
flow and initial public offering models
to facilitate investment banking
opportunities.
Prateek Agarwal
Harvard University, Cambridge, MA
A.B., Summa Cum Laude, Molecular
and Cellular Biology, 2015
Perelman School of Medicine at the
University of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to leverage my clinical
and business experience to design and
implement systems-level interventions
to improve the quality of health care
while reducing costs.
McKinsey & Company, Philadelphia, PA
Summer Associate, Summer 2019
Reviewed and optimized a pharmaceu-
tical company’s R&D portfolio using
qualitative and quantitative metrics.
Researched and pre-populated scoring
criteria for R&D opportunities and
facilitated client workshops to collect
data. Subsequently, analyzed this
data and synthesized results into
recommendations for the client.
Sanguis, Philadelphia, PA
Co-Founder, Head of Marketing
& Management, 2016-Present
Co-founded Sanguis, a medical device
start-up that empowers patients to
prevent life-threatening infections
with cost-effective, at-home neutrophil
count testing. Conducted market
analysis and developed the company’s
pricing, regulatory and reimbursement
strategy to help win first place at the
2018 Penn Wharton Entrepreneurship
Startup Challenge and raise ~$100,000
to date. Collaborated with co-founders
to submit U.S. Utility Patent and PCT
applications.
University of Pennsylvania, Department
of Neurosurgery, Philadelphia, PA
Medical Student Researcher, 2015-Present
Completed several clinical, translational
and basic science research projects that
have resulted in more than 30 peer-
reviewed publications and 25 oral
and poster presentations.
Jenna R. Ackerman
University of Pennsylvania, Philadelphia, PA
B.A., Summa Cum Laude, Economics, 2013
An opportunity to work for a mission-
driven organization in a strategic role
that advances care delivery models
and strengthens the payer-provider
relationship.
Walmart, Bentonville, AR
Health & Wellness Strategy Intern,
Summer 2019
Structured overall approach to and led
model development for site selection
for Walmart Health, a new in-store
health and wellness service offering.
Streamlined disparate efforts on site
selection process and enabled leadership
alignment on strategic goals.
The Chartis Group, Chicago, IL
Consultant, 2018
Associate Consultant, 2016-2018
Advised $1B+ U.S. health systems on
strategic and operational initiatives.
Designed and implemented population
health business unit to prepare top
academic medical center for new
risk-based products. Created compre-
hensive accountable care strategy for
rural integrated delivery network.
Developed financial model that
identified $6M in potential annual
net revenue from improved access
across 3 ambulatory clinics in major
academic system.
Berkeley Research Group, Chicago, IL
Consultant, 2016
Senior Associate, 2015
Associate, 2013-2014
Managed clinical analytics projects
and designed data visualization tools
for multi-facility health systems to
implement organizational change
and realize cost savings, specifically in
clinical variation, patient throughput,
service line optimization and human
resources.
7
Sheyda
Bautista-Saeyan
Brown University, Providence, RI
A.B., Health and Human Biology, 2014
An opportunity to lead operations and
strategy in a healthcare organization
that aims to improve access to care
while lowering costs.
DaVita, Denver, CO
Redwoods Associate, Summer 2019
Analyzed effectiveness of existing
operational strategy and management
processes of patient assessment and
selection for home dialysis treatments.
Developed and launched training and
onboarding plan improving effectiveness
of patient educators. Implemented
pipeline management tools to improve
patient education pipeline, improving
patient conversion rate.
Gartner, Washington, DC
Senior Analyst, 2016-2018
Analyst 2014-2016
Spearheaded successful global launch
of new product from inception to
commercial launch enabling sale of
150 units, creating $5M revenue
impact. Enabled CEO decision for new
product launches in 2017 by leading
two product explorations, conducting
50+ market research interviews, creating
concept plan and business case, facili-
tating senior stakeholder checkpoints,
leading sales force training, and
supporting sales interactions. Invited to
join integration team post-acquisition
to facilitate market analysis and advise
executive team on product portfolio.
Matthew S. Baker
Brown University, Providence, RI
B.A., Magna Cum Laude, Economics, 2014
An opportunity to drive change in
the healthcare system by investing in
and supporting innovative healthcare
technology and services companies.
Cityblock Health, New York, NY
Summer Fellow, Summer 2019
Developed framework for evaluating
and prioritizing new partnership
opportunities, including relative
weighting of key assessment criteria
and sources for information. Performed
analysis on unit economics of new
business and provided recommenda-
tions to senior leadership team for
contract negotiations. Spearheaded
initiative to create dashboard translating
health plan partner contracts into
strategic operating implications.
Apax Partners, New York, NY
Private Equity Associate, 2016-2018
Conducted industry, financial and
business diligence to evaluate health-
care investments for $50B AUM global
private equity firm. Developed invest-
ment theses, managed third-party
advisors and presented analysis to
investment committee. Supported
two portfolio companies (Acelity and
Ideal Protein) by performing business
analyses, leading strategic initiatives,
attending board meetings, assisting
with refinancings and evaluating M&A
targets. Executed platform acquisition
of medical cost containment solutions
business (Kepro).
Citigroup, New York, NY
Investment Banking Analyst, 2014-2016
Advised healthcare clients on M&A,
financing, and strategic alternatives
by developing valuation analyses,
performing due diligence and preparing
offering memoranda. Successfully
completed 4 transactions.
Daniel S. Astrachan
Vanderbilt University, Nashville, TN
B.S., Human and Organizational
Development, 2012
An opportunity to identify operational
improvements and define the strategy
of healthcare organizations to improve
service delivery.
UnitedHealthcare, Minneapolis, MN
Strategic Initiatives Intern, Summer 2019
Developed operational playbook out-
lining standard operating procedures
for 5 business units supporting launch
of Medicare & Retirement bundled
payment product. Identified product
performance and analytics gaps and
presented recommendations to senior
leaders who deployed two-person
team to prioritize implementation
for upcoming product release date.
VAL Health, New York, NY
Senior Manager of Strategic Analytics,
2017-2018
Senior Strategic Account Manager,
2015-2017
Strategic Account Manager, 2014-2015
Led curation and submission of $1M
government grant for development
of new program offering. Identified
opportunity to reduce expenses of key
account by 40% without compromising
program quality. Decreased program
launch time by 90% by streamlining
internal and external program imple-
mentation processes, which resulted
in the elimination of program errors.
Aon Hewitt, New York, NY
Health and Benefits Analyst, 2012-2014
Directed mental and medical health
claims financial analysis on behalf of
Department and Health and Human
Services to support publication of
medical payment legislation guidelines
published by the Department of
Treasury. Authored and evaluated
proposals to provide Fortune 500
client health insurance coverage.
8
Hannah H. Bogardus
Bowdoin College, Brunswick, ME
B.A., Cum Laude, Biochemistry, 2013
An opportunity to help bring break-
through therapies to patients by leading
strategy and operations at a pharmaceu-
tical or biotechnology organization.
Pfizer Inc., New York, NY
Pharmaceutical Marketing Summer
Associate, Summer 2019
Supported the Global Commercial
team for a rare disease asset. Involved
in strategic initiatives and tactical
activities to increase disease diagnosis
and in ensuring optimal launch timing
across markets as part of brand launch.
Led cross-functional teams, managed
relationship with creative agency and
presented launch timing recommenda-
tions to commercial leadership.
PricewaterhouseCoopers, Boston, MA
Experienced Associate, Pharmaceuticals and
Life Sciences Advisory, 2016-2018
Advised pharmaceutical companies
on R&D strategy and implemented
systems to improve efficiency and
effectiveness of R&D operations.
Led client workshops to determine
approach for R&D process improve-
ment, conducted analysis and bench-
marking to support recommended
operating models and executed
recommendations.
Health Advances, LLC, Boston, MA
Senior Analyst, Analyst, 2014-2016
Developed commercialization
strategies for new and existing products
and services for pharmaceutical, bio-
technology and medical device clients.
Directed primary research with clinical,
regulatory, pricing and industry
experts; led market assessments;
made strategic recommendations
to maximize ROI for clients.
Boston Children’s Hospital, Boston, MA
Research Assistant, 2013-2014
Executed research protocols, analyzed
experimental results and contributed
to two publications.
Joseph
Laurence Blundo
Babson College, Wellesley, MA
B.S., Summa Cum Laude, Business
Administration, 2013
An opportunity to build successful
healthcare technology companies
through a private equity investing role.
Watermark, New York, NY
Acting Head of Financial Planning & Analysis
(“FP&A”), Summer 2019
Responsible for leading the development,
introduction, and roll-out of both
Redshift (Amazon Web Services) data
warehouse and Qlik dashboards.
Managed team of three data scientists
to author computer script for performing
sales, marketing, and financial analyses.
Technology Crossover Ventures (“TCV”),
New York, NY
Associate, Private Equity, 2015 – 2018
Identified and sourced $50M+
investment opportunities across
vertical software and services categories
spanning 6,000+ companies. Performed
market sizing work, customer and
management references, product
assessments, and customer cohort,
unit economics, and in-depth financial
modeling to evaluate deal structures
and returns. Provided portfolio
support for Watermark, tastyworks,
HireVue, Payoneer, OneSource
Virtual, and Avalara (NYSE: AVLR).
Harris Williams & Co., Boston, MA
Analyst, Investing Banking, 2013 – 2015
Authored sell-side M&A transaction
marketing and process materials,
developed financial models and analyses,
and facilitated multi-party due diligence.
Spearheaded creation of TMT Group’s
Quarterly Software Sector Review,
which was distributed to several
thousand TMT Group contacts for
marketing purposes.
Elisabeth G. Berger
Brown University, Providence, RI
Sc.B., Cum Laude, Biomedical Engineering,
2014
An opportunity to build predictive
software systems that improve
quality of care for patients.
The One Health Company, Palo Alto, CA
Product Marketing Intern, Summer/Fall 2019
Prepared for series A fundraising by
developing pitch deck, managing VC
funnel, and analyzing key metrics
including TAM, LTV and CAC. Created
marketing content for B2B and B2C
channels.
Maven Ventures, San Francisco, CA
Summer VC Associate, Summer 2019
Supported the deal process for consumer
software VC by performing due
diligence and preparing investment
memos in 3 investment areas resulting
in 2 successful deals. Developed
startup onboarding kit and managed
series A fundraising efforts of
portfolio company.
Syapse, Inc., San Francisco, CA
Senior Product Manager, 2017-2018
Led a technical team of engineers,
data architects and designers to
deliver real-world evidence analytics
ecosystem. Launched initial product
with internal data science team and
external large pharma customer.
Change Healthcare, Emeryville, CA
Senior Product Manager, 2016-2017
Product Manager, 2014-2016
Led 3 engineering teams and 2 junior
product managers to deliver data
aggregation platform including
underlying architecture, data ontology,
terminology normalization, HIPAA
de-identification and data curation
capabilities. Invented and patented
tool for human-assisted curation of
duplicative records. Founded Workout
Wednesday and Dessert Competition
events.
9
Andrew A. Bravo
Williams College, Williamstown, MA
B.A., Cum Laude, Chemistry and Economics,
2015
An opportunity to build solutions that
maximize patient health by targeting
areas of highest unmet need.
Eden Health, New York, NY
MBA Intern – Business Development,
Summer 2019
Created proprietary database of
2,000+ employers to enable targeted
sales outreach in NY, Washington
D.C. and Chicago. Developed process
to create partnerships between Eden
Health & employee benefits brokers,
driving future sales opportunities. Led
internal sales operations improvement
processes; reduced time required to
identify sales cohorts from 5 days to
15 minutes.
Bain & Company, Boston, MA
Senior Associate Consultant, 2017-2018
Associate Consultant, 2015-2017
Associate Consultant Intern, 2014
Management consultant specializing
in healthcare. Project highlights: (1)
Created strategic, value-based play-
book in key healthcare markets for
national payor. (2) Evaluated global
pharmaceutical portfolio to determine
which products to introduce to
American and European markets.
Additional projects in private equity,
pharmaceutical, medical technology,
and retail sectors.
3Derm Systems, Boston, MA
Program Manager, 2017-2018
Oversaw development of new business
opportunities and alternative revenue
streams, reporting to CEO. Managed
growth projection model and pitch
deck, providing basis for Series B
fundraising negotiations. Applied
product design thinking principles
with CTO to create proposal for soft-
ware to train dermatology students.
Frederic F.
(Beau) Brace
Cornell University, Ithaca, NY
B.S., with Honors, Industrial and Labor
Relations, 2013
An opportunity to build and scale
leading healthcare businesses through
a private equity investing role.
Post Capital Partners, New York, NY
MBA Intern, Summer 2019
Evaluated investments in healthcare
and technology-enabled services
businesses for a middle-market private
equity firm investing out of a $100M
fund. Spearheaded due diligence on
7 potential platform investments
within a home- and community-based
care investment thesis.
Sheridan Capital Partners, Chicago, IL
Associate, Private Equity, 2015-2018
Evaluated, executed and managed
leveraged buyout investments in
companies across the healthcare space
for a middle-market private equity
fund with $450M of committed capital.
Served as interim head of FP&A for
distressed portfolio company, working
on-site with 15-member executive
leadership team. Managed multiple
due diligence streams for 2 practice
management platform investments, 17
add-on transactions and 1 distressed
recapitalization. Negotiated credit
documents, managed credit facility
expansions and participated in
negotiation of transaction documents.
Lazard Frères & Co., New York, NY
Analyst, Global Healthcare Group,
2013-2015
Supported senior professionals in the
sourcing and execution of mergers and
acquisitions mandates for large-cap
clients across the healthcare space.
Performed valuation analyses including
DCF analyses, public comparable analyses
and precedent transaction analyses.
Drafted fairness opinion presentation
materials.
Shane R. Bouchard
Harvard University, Cambridge, MA
A.B., Magna Cum Laude, Chemistry, 2014
A.M., Chemistry, 2014
An opportunity to support innovative
biotechnology companies in translating
science into transformative medicines
through a business development,
strategy or operations role.
Magenta Therapeutics, Cambridge, MA
Business & Corporate Development Intern,
Summer 2019
Developed term sheets and contributed
to presentations for strategic partnering
discussions. Spearheaded execution
of business operations contracts. Led
external consultancy in conducting
pricing and market access research
and integrated output into business
case for lead clinical programs. Built
commercial readiness roadmap for
Magenta; presented to full Executive
Team and integrated into Board
presentation.
Clarion | A Life Sciences Consultancy,
Boston, MA
Manager, 2018
Consultant, 2016-2017
Associate Consultant, 2014-2015
Led multiple concurrent case teams,
providing day-to-day leadership,
developing conceptual frameworks,
coaching team members and acting
as primary client contact. Managed
projects generating >$1.1M and devel-
oped proposals securing >$400,000 in
revenue over final year at firm. Helped
launch PatientLink initiative, connecting
Clarion teams with patients impacted
by clients’ medicines. Project high-
lights: (1) Managed team in assessing
in-licensing opportunities for mid-cap
specialty pharmaceutical company;
(2) Developed gene therapy strategy
for large-cap biotech company; (3)
Supported top-10 multinational pharma
company in developing patient support
program generating 2:1 ROI and
reaching over 160,000 patients.
10
Evan Cairo
The Wharton School,
University of Pennsylvania, Philadelphia, PA
B.S., Cum Laude, Finance, 2013
An opportunity to build, invest in
and direct market-leading healthcare
services companies.
Johnson & Johnson, San Francisco, CA
MBA Intern (Health Tech Partnerships),
Summer 2019
Developed Apple partnership strategy
and recommended specific digital
opportunities within mental health
that contributed to a new Apple-J&J
collaboration.
Moelis Capital Partners, New York, NY
Private Equity Associate, 2016-2018
Conducted industry, financial and
business diligence to evaluate health-
care investments for $1.3B AUM private
equity firm. Developed investment
theses, managed third-party advisors,
arranged debt financing, negotiated
credit & purchase agreements, and
presented recommendations to invest-
ment committee. Executed platform
acquisition of Clearway Pain Solutions
Institute, an interventional pain
management provider. Supported
3 portfolio companies by serving as
a board observer, developing strategic
initiatives, monitoring financial perfor-
mance, and evaluating M&A targets.
Deloitte Corporate Finance, New York, NY
Investment Banking Analyst, 2013-2016
Executed M&A transactions across
the healthcare sector including
Medtronic’s sale of its surgical instru-
ment business to Integra LifeSciences,
Magellan Health’s acquisition of
TMG, and Astellas Pharma’s sale of
its commercial manufacturing business
to Avara. Directed day-to-day execution
of transactions, including creating
go-to-market materials, managing
deal marketing processes, conducting
financial analysis, and coordinating
due diligence.
William D. Burton
Brigham Young University, Provo, UT
B.A., Cum Laude, Chemistry, 2014
An opportunity to lead the operations
of innovative and value-based health-
care services organizations.
J.P. Morgan, New York, NY
Summer Associate – Investment Banking,
Summer 2019
Advised companies across healthcare
spectrum on strategic financial oppor-
tunities. Worked on a large biotech
buy-side process, a life science tools
sell-side process, and a healthcare
services IPO among other projects.
Led valuation analyses and financial
modeling in addition to research and
diligence efforts.
DaVita Medical Group,
Colorado Springs, CO
Director and Sr. Manager– Operations,
2017-2018
As Director of Primary Care Operations
for a subsidiary of DaVita, Inc., I oversaw
a $40M P&L including a portfolio of
primary care clinics and 60 providers;
achieved 50% YoY operating income
improvement. Had responsibility for
day to day operations and strategic
turnaround initiatives. Additionally,
ran special projects related to opera-
tional and financial performance of
broader enterprise service lines.
DaVita Inc, Denver, CO
Sr. Analyst and Analyst – Corporate Strategy,
2014-2016
Developed and advanced strategies
for C-level executives and boards of
directors across multiple business units.
On the medical group business line,
led successful re-contracting efforts
for large hospital system worth $250M
in annual spend and large physician
group worth $15M in contribution
margin.
Jordan Brown
University of Pennsylvania, Philadelphia, PA
B.A., Magna Cum Laude, Health and Societies,
2012
An opportunity to invest in and
support the expansion of growth-
stage healthcare companies
Varian Medical, Palo Alto, CA
Strategy & Corporate Development Intern,
Summer 2019
Engaged in strategy development for
leading radiation oncology medtech
and software solutions provider.
Assessed strategic opportunities in
EMRs, data and technology-enabled
services. Evaluated medtech companies
for investment and acquisition.
1315 Capital, Philadelphia, PA
MBA Intern, Summer 2018
Evaluated healthcare services, medtech
and specialty therapeutics companies
for growth equity investment. Sourced
and introduced firm to hospital venture
organizations, resulting in investment
opportunities and investor day and
dinner. Conducted “white space
analysis” and made recommendations
on identified investment sector.
Northwell Ventures, Manhasset, NY
Direct Equity Investments Analyst,
2016-2018
Managed due diligence and
investment into 5 medtech and digital
health companies through $50M
corporate venture capital allocation
(Seed to Series B). Supported portfolio
company management on strategic
initiatives. Worked with Northwell
physicians and employees to spin-out
technology and services into new,
standalone ventures.
Retrophin, New York, NY
Business Development Manager, 2014-2016
Sourced and conducted diligence on
5 biopharmaceutical assets in rare
disease for acquisition. Managed
out-licensing initiative in Asia-Pacific
region, including sourcing of partners
and evaluation of term sheets.
11
Rita Costiv
Northeastern University, Boston, MA
B.S., Finance and Marketing, 2014
An opportunity to develop and lead
strategies designed to innovate current
healthcare practices with the goal of
improving quality of care and delivery
for both patients and providers.
Accenture Strategy, New York, NY
Senior Strategy Consultant, Summer 2019
Collaboratively managed organization
design workstream during a pre-merger
integration for a global biopharma-
ceutical company undergoing an
acquisition. Developed training
material, analyzed data and provided
solutions to alignment complexities
to ease facilitation of organization
design of the combined company.
Longevity Care, Inc., Newton, MA
Co-Founder, 2012-Current
Co-founded and successfully developed
a healthcare company providing
personalized home health care services
to elderly and disabled adults with
the goal of minimizing their risk of
hospitalization. Developed growth
strategies including expansion of
company network and company
relationships with outside organizations
creating long term stability. Continuously
redesigned and improved workflows
and wage structures resulting in
increased profitability.
East Boston Neighborhood Health
Center, East Boston, MA
Operations Manager, 2016-2018
Co-managed a busy Family Medicine
department serving over 300 patients
daily in the largest continental U.S.
nonprofit health center. Optimized
departmental workflows ensuring
high efficiency and productivity
amongst providers and support staff.
Worked as a liaison between other
specialty and support practices to
improve care for patients and delivery
support for providers.
William J. Choi
Wesleyan University, Middletown, CT
B.A., Economics, 2013
An opportunity to invest in, partner
with, and build leading healthcare
services and technology companies
New Mountain Capital, New York, NY
MBA Intern, Summer 2019
Conducted business diligence for
the acquisition of a provider of
revenue cycle management software.
Supported investment teams across
private equity, credit and net lease
strategies. Accepted offer to return
full-time as a Senior Associate.
Vestar Capital Partners, New York, NY
Associate, 2016-2018
Evaluated and executed private equity
investments across healthcare, consumer
and business services & industrial prod-
ucts sectors as part of a team of ~25
investment professionals managing
~$5B of capital. Completed one
platform acquisition of a provider of
network management and analytics
solutions to health plans and subse-
quent add-on of a provider of physician
directory data accuracy solutions.
Managed several portfolio companies
across healthcare and business services
verticals, attending Board meetings,
monitoring performance, and driving
strategic and operational initiatives.
Perella Weinberg Partners, New York, NY
Analyst, 2014-2016
Conducted financial analyses and due
diligence on mergers and acquisitions
advisory assignments for clients across
the medical devices, life science tools
and diagnostics industries. Executed
two transactions across M&A and
capital markets advisory.
Amanda L. Chin
University of Pennsylvania, Philadelphia, PA
B.A., Magna Cum Laude, Biochemistry, 2015
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to collaborate with
industry, hospitals, and payers to
develop and integrate novel surgical
devices into clinical practice to provide
safe and cost-effective care to patients.
Boston Scientific Corporation,
Maple Grove, MN
Marketing Associate Intern, Summer 2019
Developed a targeted strategy within
the US launch of the LOTUS Edge
Transcatheter Aortic Valve System
and the SENTINEL Cerebral Embolic
Protection System to engage with
cardiac surgeons and valve clinic
coordinators.
Hospital of the University of
Pennsylvania, Department of Surgery,
Philadelphia, PA
Clinical Research Assistant, 2016-Present
Studied trends in open aortic surgery
for abdominal aortic aneurysm repair in
the context of the growing prevalence
of endovascular aneurysm repair
(EVAR). Findings were presented at
the Society for Vascular Surgery 2019
Vascular Annual Meeting.
Navigant Consulting, New York, NY
Summer Intern, Summer 2014
Assisted clients in the pharmaceutical
and medical device industries in a wide
range of business issues including
market analyses, strategic planning,
and business development. Initiated
the formation of a physician advisory
board for a global biopharmaceutical
company planning upcoming Phase III
clinical trials of a novel drug for
Crohn’s disease.
12
Katherine
M. Dunnigan
University of Florida, Gainesville, FL
M.S., Biomedical Engineering, 2014
B.S., Biological Engineering, 2013
Accelerated 4+1 degree program
An opportunity to strategically build
and scale innovative and evidence-based
healthcare solutions that improve the
efficiency and cost of care delivery.
Goldman Sachs, New York, NY
Investment Banking Summer Associate,
Healthcare Group, Summer 2019
Advised top healthcare services and
biotech companies on various transac-
tions, including a confidential filing
for an initial public offering of a
services company, due diligence on
potential strategic exit alternatives
for a sponsor-owned spec pharma
company and valuation of a potential
acquisition target for a large services
company.
Advisory Board, Washington DC
Strategy Consultant, 2018-2019
Advised payors and providers on
strategic initiatives, including growth
strategy of a patient navigation
program to increase patient loyalty
and reduce leakage, business plan
development for a potential joint
venture for a large health system,
pricing strategies with a focus on
transparency and Medicare Advantage
strategic partnerships.
Accenture, Dallas, TX
Management Consultant, Life Sciences,
2016-2017
Analyst / Senior Analyst, Life Sciences,
2014-2016
Advised top pharma companies on
compliance strategies for new global
serialization regulations. Select experi-
ences: created $50M serialization
budget, coordinated change manage-
ment across ~20 global packaging
sites, developed internal North
America Life Sciences people program.
Elizabeth
A. Duckworth
Claremont McKenna College, Claremont, CA
B.A., Magna Cum Laude,
Science & Management, 2014
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to utilize clinical and
managerial skills to align stakeholder
incentives across healthcare delivery
systems.
Butternut Box, London, UK
MBA Intern, Quality Assurance
& Compliance, Summer 2019
Analyzed compliance requirements for
the company’s expansion into the E.U.
in hard-Brexit versus soft-Brexit scenarios
and shared recommendations with
founders and Board of Directors.
Augmented back-end compliance
systems, including reimagining the
supplier on-boarding process, expanding
the company’s knowledge library and
building a suite of tools for measuring
compliance with E.U. requirements.
Bioactive Surgical, Baltimore, MD
Research Assistant, 2014
Collected pre-clinical data to support
an Innovative New Drug application to
the U.S. Food and Drug Administration.
Performed in-vitro experiments,
including maintaining stem cell lines
and conducting cell viability assays, as
well as processing animal tissue samples
and coordinating future animal studies.
Steelcase Inc., San Francisco, CA
Intern, WorkSpace Future & Corporate
Strategy, 2012
Conducted primary and secondary
research on innovation, investment
models, organizational structure and
work culture trends in Silicon Valley
to help the world’s largest office
furniture manufacturer understand
and adapt to the future of work.
William C. Davenport
Yale University, New Haven, CT
B.A., Molecular, Cellular, and Developmental
Biology, 2015
An opportunity to improve strategy and
operational efficiency for an innovative
health care company.
Professional Golf, Philadelphia, PA
Tournament Golfer, Summer 2019
Prepared to pursue short-term
professional golf aspirations with
a competitive amateur tournament
campaign. Won several events,
including the Philadelphia Mid-Amateur
Championship and National Mid-
Amateur Championship Qualifying,
en route to an upcoming bid at
PGA Tour Qualifying School.
Boston Consulting Group, Miami, FL
Consultant, 2017-2018
Associate, 2016-2017
Summer Associate, 2014
Transformed supply chain operations
of a major biopharmaceutical company,
including supply planning, logistics,
and life cycle management of the
company’s most prominent drugs.
Assessed and advised digital biometry
strategies for a French biotech
company. Contributed to BCG’s
published knowledge base on
operational efficiency in health
care and worked in over 15 countries,
including a year based in the
Melbourne office.
13
Charles J. Gage
University of North Carolina, Chapel Hill, NC
B.S., Business Administration and Economics,
2013
University of Pennsylvania, Philadelphia, PA
J.D. Candidate, 2020
An opportunity to improve care delivery
and health outcomes through techno-
logical innovation, strategic decision-
making and operational excellence.
Boston Consulting Group, Atlanta, GA
Summer Consultant, Summer 2019
Transformed complex military aviation
organization through data analysis
and application of commercial best
practices. Planned and conducted
innovation workshop and pitch
competition for 24 enlisted military
personnel, resulting in fleet-wide
adoption of winning idea that will
save 6,000 man-hours per year.
Developed metric report set for
performance evaluation of aircraft
maintenance crews.
Huron Consulting Group, Washington, DC
Associate, 2015-2017
Analyst, 2013-2015
Led teams of analysts on Revenue
Cycle performance improvement,
technology implementation and post-
merger integration strategy projects
resulting in $150M+ cumulative benefit
for 8 health systems and associated
physician groups. Performed extensive
data analysis to isolate payer trends,
reduce denials and increase cash flows.
Designed and built hybrid in-house
self-pay collections team and vendor
outsourcing model for hospital client.
Daily interaction with client managers,
directors and executives.
Annie M. Fox
Amherst College, Amherst, MA
B.A., Neuroscience, 2014
An opportunity to improve health care
access and quality through strategic and
technological innovation.
Manatt Health, New York, NY
Summer Analyst, Summer 2019
Collaborated with a range of care
organizations (hospitals, medical
schools, research institutes) on
strategic planning; performed data
analysis and current state assessments
and drafted organizational and
financial models for a joint venture.
Population Council, Lusaka, Zambia
Global Health Corps Fellow, 2017-2018
Served as Director of Growth for a
Kenya-based digital health startup
and as an Informatics Officer for a
Zambian non-profit. Led first-ever
user acquisition strategy for core
digital product; established 80+ person
task force and increased product users
900% in 3 months. Evaluated a $10M
initiative to increase Zambia’s family
planning services; identified opportu-
nities to improve supply chain
efficiency and patient satisfaction,
reporting to Ministry of Health and
United Nations Population Fund.
Genoa Telepsychiatry (UnitedHealth),
New York, NY
Physician Partnerships Manager, 2015-2017
Led strategy to grow national physician
network, increasing provider partners
500% in 1 year. Co-led scaling of internal
Physician Partnerships team, setting
team vision and designing and imple-
menting organizational structure.
Brigham and Women’s Hospital,
Boston, MA
Neurology Research Assistant, 2014-2015
Co-led clinical research study,
collecting, processing, and analyzing
brain wave data for 100+ participants.
Jennifer L. Fernández
American University, Washington, DC
B.A., Cum Laude, International Studies and
Business Administration, 2013
An opportunity to work with and
within strategic organizations to drive
improvements and innovations in care
delivery and healthcare outcomes.
GlaxoSmithKline, Philadelphia, PA
Esprit Pharmaceutical Commercial Intern,
Summer 2019
Performed market assessment to
define trends and product portfolio
sales growth opportunities in the retail
pharmacy and clinic space. Developed
a strategic plan and advised large
cross-functional team on tactical
recommendations to evolve organiza-
tional procedures to support product
education and sales efforts in the
retail setting.
Deloitte Consulting, Washington, DC
Senior Consultant, 2018
Consultant, 2016-2018
Business Analyst, 2015-2016
Worked on 6+ strategic and operational
projects across two Federal healthcare
agencies. Primary project areas
included: oversight and execution of
a maturity assessment of a primary
care patient centered medical home
model, formation of a strategic plan
for trauma care in the U.S. Navy, and
development and implementation of a
performance management framework
to support quality and safety strategic
initiatives. Led teams of consultants to
support program and performance
management efforts across multiple
workstreams.
Biotechnology Industry Organization,
Washington, DC
Coordinator, 2013-2015
Oversaw development of company
presentation programming for 6+
annual industry trade conferences,
and managed outreach, marketing,
and communications to over 6,000
biotechnology and pharmaceutical
executives.
14
Michael P. Greenberg
University of Pennsylvania, Philadelphia, PA
B.A., Biological Basis of Behavior, 2012
B.S., Economics (Finance Concentration), 2012
An opportunity to build innovative
healthcare companies as an investor
or strategy professional.
Genentech, South San Francisco, CA
Business Development Summer Associate,
Summer 2019
Created business development strategy
and comprehensive landscape analysis to
enable novel partnering and investment
transactions within neuroscience.
Conducted diligence screens and term
sheet negotiations and supported
cross functional teams composed of
internal scientific researchers, in-house
legal counsel, and finance team members
to execute research collaborations,
MTAs, and in-licensing deals.
PureTech Health, Boston, MA
Director, Strategy and Corp Dev, 2018
Senior Manager, Strategy and Corp Dev, 2017
Manager, Strategy and Corp Dev,
2016-2017
Led diligence process in respiratory
and infectious disease space resulting in
initial investment, company formation
and eventual IPO of new portfolio
company, resTORbio (NASDAQ:TORC).
Developed capital allocation strategies
to support investment decisions and
long-term growth for the firm.
Managed disease-area prioritization
for multiple portfolio companies,
resulting in redirection of venture
financing proceeds towards development
in multiple additional disease areas.
Leerink Swann Consulting, New York, NY
Managing Consultant, 2015-2016
Senior Consultant, 2014-2015
Analyst, 2012-2014
Advised senior executive biopharma
clients on a range of strategic business
projects such as financial valuations,
pipeline prioritizations, asset scans,
and competitive landscape assessments.
Jan Gong
Harvard College, Cambridge, MA
A.B., Magna Cum Laude, Chemical and
Physical Biology, 2015
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to use my experience
in clinical practice and basic science
research to bring innovative therapeutics
to market.
Commodore Capital LP, New York, NY
Investment Analyst Intern, Summer/Fall 2019
Conducted investment diligence of
small- and mid-cap biotechnology
companies.
Marshall Wace LLP, New York, NY
Investment Analyst Intern, Summer 2019
Conducted investment diligence of
biotechnology and pharmaceutical
companies as part of the Global
Healthcare Team.
RTW Investments, LP, New York, NY
Biotechnology Research Intern,
Winter/Spring 2018
Identified and evaluated candidate
diseases and targets for novel gene
therapies to support portfolio companies.
Reena E. Glaser
Princeton University, Princeton, NJ
A.B., Summa Cum Laude, Psychology, 2014
An opportunity to create equitable
access to healthcare via digital customer
experience.
Cerner Corporation, Kansas City,
Missouri
Product Manager, Summer 2019
Developed market strategy, business
case and technical requirements for
patient-to-provider messaging product
line in $19B patient engagement
market. Modeled proof of concept
for one-way and two-way text
messaging applications.
Deloitte Consulting, Arlington, VA
Consultant, 2016-2018
Managed technical team of 5 to
engineer an access to care dashboard
to proactively reduce wait times across
170 medical centers. Convened 20
R&D experts to establish a formal
process accelerating clinical product
development and distribution for
an international hospital network.
Deloitte Consulting, Arlington, VA
Business Analyst, 2014-2016
Advised hospital C-suite on distribution
of $234M budget and 2,700 employees
to meet patient demand. Constructed
predictive time series models and metric
definitions for 12 industry benchmarks
to monitor $50B budget allocation
across a global health system. Devised
implementation planning and reporting
strategy for national cancer prevention
and screening programs at a public
health agency.
15
Elston He
Harvard College, Cambridge MA
A.B., Cum Laude, Philosophy, 2013
University of Pennsylvania Law School, Phila-
delphia, PA
J.D. Candidate, 2020
An opportunity to build products and
invest in companies that improve health
outcomes and costs through innovation
Roivant Sciences, New York, NY
Product Manager | Strategic Investments,
Summer 2017-Present
Own data analytics product for clinical
trial risk assessment and operational
feasibility, utilizing data from thousands
of previous trials across phases and
therapeutic areas – a core offering of
a multi-year, $10+M product develop-
ment deal. Diligenced $20M opportunity
for next-generation clinical trials solution
utilizing NLP to extract EHR data and
enroll eligible oncology patients across
under-penetrated trial sites.
Guggenheim Partners, New York, NY
Associate, 2015-2017
Led due diligence, structuring, and
execution for multiple investments
across a wide spectrum of products
(high yield, direct lending, structured
equity) and industries (healthcare,
consumer, financial services), deploying
over $100M+ in new investments for a
$12B credit fund. Provided healthcare
industry coverage, focusing on health-
care information technology, payors,
and providers.
Citigroup Global Markets, New York, NY
Analyst, 2013-2015
Developed firm’s research efforts in
the continuing care space, developing
tradable credit views and relative
value pricing on all new issue bond
issuances across CCRC, SNF, and
assisted living facilities.
Alexandra M. Hariri
Princeton University, Princeton, NJ
A.B. Ecology and Evolutionary Biology, 2013
Georgetown University, Washington DC
M.S. Biotechnology, 2017
An opportunity to bring novel, innovative
therapies to patients through business
development in the biotechnology
industry.
Cornell University Department
of Neurosurgery, New York, NY
Intern, Summer 2019
Gained clinical experience and
operational insights while alongside
the chair of the department of neuro-
surgery in both the outpatient setting
and the operating room. Gained
perspective on the evolving challenges
in managing a world-class academic
surgical department.
Celularity, Warren, NJ
Corporate Strategy and Business
Development, Summer 2018
Identified potential competitors and
partnerships relevant for the company’s
therapeutic assets.
LifebankUSA
Associate Director of Business
Development, 2013-2014, 2016-2018
Served as an associate in business
development and marketing to create
new strategic partnerships across 3
business lines. Created new marketing
strategy including updating all
promotional materials.
OXSTEM, Oxford, UK
Business Development, September 2016
Conducted business intelligence
research to identify possible collaborators
and created term sheet.
Scientific American Publishing
Project Management, 2014-2015
Developed web and print content for
advertising and promotion campaigns.
Planned and executed events for
Worldview Magazine and served as
editorial associate for Worldview
‘Future of Transportation’ Edition and
Worldview 100.
Christopher
H. Greeno
Williams College, Williamstown, MA
B.A., Cum Laude Biology and Economics, 2014
An opportunity to bring new products
to patients at innovative biotechnology
or life sciences companies in a business
development or operations role.
BridgeBio Pharma, San Francisco, CA
Business Development Intern, Summer 2019
Drove business development and
commercial strategy projects for two
of BridgeBio’s lead subsidiaries: QED
Therapeutics and Origin Biosciences.
Engaged in partnership discussions,
conducted diligence and handled
requests from potential partners. Led
analysis of Origin’s E.U. commercial
opportunity, reimbursement pathways
and partnership strategy. Owned com-
petitive intelligence analysis for QED’s
oncology indications, guiding updates
to confirmatory trial designs.
Clarion | A Life Sciences Consultancy,
Boston, MA
Consultant, 2017-2018
Senior Associate Consultant, 2016-2017
Associate Consultant, 2014-2016
Led teams, managed clients and
coached team members on 2-3 month
growth strategy projects. Project
highlights: (1) Led team in developing
cash-flow model for lead asset of a
digital therapeutics company. Model
used to support procurement of $60M
in series-C financing. (2) Headed team
to develop analytics-based market
access assessment and payer targeting
approach for $1B+ biologic. (3) Owned
relationship and provided strategic
guidance to client at a top-5 pharma,
overseeing design of a KPI tracking
tool for a 100,000+ patient support
program.
16
Olivia S. Jew
Stanford University, Stanford, CA
B.A. with Honors, Human Biology, 2014
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2019
An opportunity to leverage my clinical
background and business experience
to enhance care delivery.
Bain & Company, San Francisco, CA
Summer Associate, Summer 2019
Evaluated the cell therapy space for
potential investment opportunities,
work that was soon thereafter
incorporated into Bain’s investment
point-of-view. Modeled manufacturing
capacity for a raw material for gene
therapy in a multi-billion-dollar asset
diligence. Spearheaded the analysis of a
drug analog for a $1B+ client preparing
a drug launch, including interviews
with key stakeholders.
Children’s Hospital of Philadelphia,
Philadelphia, PA
Lead Investigator, 2016-2020
Teamed with clinicians, hospital
leadership and software developers
to pilot a teledermatology mobile
application that reduced wait times
by >180x. Executed a pilot for a
teledermatology consultation for
primary care providers that improved
diagnostic accuracy for >40 patients.
Resulted in $185,000 in funding to
establish teledermatology program.
Stanford Program in Human Biology,
Stanford, CA
Course Instructor, 2014-2015
Led structured discussion sections
for >200 students, write exams and
mentor students on a team of 4
instructors. Partnered with award-
winning Stanford department chairs
to reform curriculum and manage
conflict by ensuring transparency in
the grading process.
Scott Z. Heyman
The Johns Hopkins University, Baltimore, MD
B.A., Phi Beta Kappa, Public Health Studies,
2012
An opportunity to improve patient
outcomes in a strategic role that combines
care delivery, patient engagement, and
technological innovations.
Humana, Inc., Louisville, KY
Risk Management Intern, Summer 2019
Prepared research and initial draft of
white paper supporting proposed CMS
and ONC legislation regarding data
interoperability. Defined Humana’s
four core values for data sharing,
identified accompanying business
use cases and established performance
metrics across four operational domains
to measure success.
FTI Consulting, Washington, DC
Director, 2017-2018
Senior Consultant, 2014-2017
Managed teams of consultants,
designed project plans and oversaw
execution or quantitative and qualitative
analyses of large client data sets across
multiple platforms for use in econometric
analyses, health forecasting, antitrust
enforcement and regulatory compliance.
Drafted reports and presented results
to healthcare executives, lawyers and
government regulators for M&A
transactions and litigation cases
exceeding $100M.
Compass Lexecon, Washington, DC
Analyst, 2012-2014
Utilized STATA, Excel and ArcGIS for
statistical, economic, and geographical
analyses for antitrust cases. Developed
charts and tables to summarize results
for expert reports and presentations
for the healthcare, life science, tourism
and manufacturing industries. Led
meetings with clients/lawyers to
present analytical results for 15+ M&A
transactions.
J. Andres Hernandez
University of Central Florida, Orlando, FL
B.S., Summa Cum Laude, Biomedical Sciences,
2015
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia PA
M.D. Candidate, 2020
An opportunity to help patients through
cutting-edge surgical technique and
thoughtful healthcare leadership.
University of Pennsylvania, Division
of Plastic Surgery, Philadelphia, PA
Sub-Intern, Summer 2019
Completed clinical rotations at the
Hospital of the University of
Pennsylvania, Massachusetts General
Hospital, and Duke Hospital, all
focused on reconstructive plastic
surgery. Continued research within
the field and converted team’s
operative experiences to projects
which have resulted in publication.
University of Pennsylvania, Division of
Plastic Surgery, Philadelphia, PA
Research Associate, 2016-2019
Conducted surgical outcomes research
focused on reconstructive microsurgical
involvement in interdisciplinary
care teams, culminating in multiple
publications and national conference
presentations. Additionally, designed
and implemented study protocol
focused on advanced imaging tools
for analysis of surgical candidates
pre-operatively.
Twine Labs, Philadelphia, PA
Summer Business Operations Intern, 2016
Spearheaded lead generation in
early-stage startup focused on internal
mobility, which resulted in company’s
first users. Led promotions and
marketing, culminating in coverage
by multiple news outlets.
17
Kathryn H. Kelley
Harvard College, Cambridge, MA
A.B., Cum Laude, Human Evolutionary
Biology, 2014
Peking University, Beijing, China
Master of International Relations, 2017
An opportunity to improve support for
global health startups and innovations
to achieve scale
Gates Foundation, Seattle, WA
MBA Intern, Summer 2019
Led assessment of how the Vaccine
Delivery team can better support
global health startups achieve scale.
Conducted interviews with startup
CEOs, global health investors and experts
to understand gaps and challenges as
well as interviews with different teams
at the foundation to learn about the
various creative financing techniques
they employ. Presented findings and
recommendations to senior leadership
within Global Delivery Programs.
Trinity Partners, Waltham, MA
Consultant, 2016-2017
Senior Associate Consultant, 2015-2016
Associate Consultant, 2014-2015
Advised leading and emerging
pharmaceutical and biotech firms
across dozens of therapeutic areas.
Completed 30 projects focusing on
qualitative and quantitative market
research, strategic planning, roadmap
launch planning, forecast creation,
prioritization and competitive strategy.
Managed 2-3 associates per project
on 16 projects. Project highlights: 1)
Co-led a $500K engagement with a
Fortune 500 company; improved and
supported quarterly forecasting cycles
for key oncology product worth
$450M in annual sales, 2) Developed
strategic launch plan roadmaps for
two orphan products; traveled to
Brussels to conduct launch planning
workshops with senior executives.
Sam A. Kahn
University of Florida, Gainesville, FL
M.S., Finance, 2013
B.S., Finance, 2012
Drive change through investing in and
helping build market-leading companies.
Blackstone, New York, NY
Private Equity Senior Associate,
Summer 2019
Member of the Private Equity team.
Participated in all aspects of the
investment process, including thesis
development, conducting financial
and business due diligence, and
presenting to the firm’s investment
committee, ultimately leading to the
completion of a new platform invest-
ment. Received and accepted offer to
return full-time.
GI Partners, San Francisco, CA
Private Equity Senior Associate, 2015-2018
Member of the Healthcare Private
Equity team. Completed 2 multi-asset
platform investments, 5 add-on
acquisitions, 2 debt re-pricings, 1
secondary public offering, and 2
multi-LP co-investments. Oversaw
4 portfolio companies, monitoring
performance and partnering with
management teams to execute value
creation plans.
Jefferies, New York, NY
Investment Banking Analyst, 2013-2015
Member of the Mergers & Acquisitions
team. Executed 6 M&A transactions
representing over $5B in transaction
value across the healthcare, technology,
industrials, and consumer sectors.
Yiqin Jiang
Williams College, Williamstown, MA
B.A. Magna Cum Laude, Biology and
Psychology, 2013
An opportunity to have a high impact in
improving the lives of large populations
of patients while touching the core
provider-patient relationship
Genentech, South San Francisco, CA
MBA Commercial Summer Associate,
Summer 2019
Spearheaded development of patient-
facing digital assets (website, display
banners and SEM) for rare-disease
indication by aligning a broad team
of agency and internal partners with
the patient journey and brand strategy.
Palladium, New York, NY
Senior Consultant, 2017-2018
Consultant, 2015-2017
Associate Consultant, 2013-2015
Advised and coached public and
private organizations across several
industries on execution and monitoring
processes (such as strategy maps,
scorecards and initiative prioritization)
designed to help them achieve their
long-term strategies. Specialized in
developing ecosystem-based strategies
for biopharma multinational companies
to succeed in emerging markets by
integrating financial and social out-
comes. Led consulting engagements as
primary client relationship and project
manager. Additionally, served as internal
regional Chief of Staff, with purview
over strategic planning and execution,
new product development, cross-func-
tional integration and internal commu-
nications.
18
Andrew D. Lay
Duke University, Durham, NC
B.S., Biology, 2013
An opportunity to contribute to the
strategy and operations of health
care delivery organizations and to the
success of entities and patients that
support, invest and depend on them.
Oliver Wyman, San Francisco, CA
Summer Associate, Summer 2019
Developed a 5-year service line strategy
roadmap for a $3B regional health
system, delivering an innovative
approach to front door clinical access,
recommendations for physician practice
redesign, and guidance around
optimizing care team ratios and overall
provider staffing. Collaborated to
build a service line analytics model,
combining claims data and actuarial
analysis to project future demand for
health care services to inform capacity
planning, site allocation and partnership
strategy.
MAXIMUS Inc., Reston, VA
Manager – Strategy and Market
Development, 2017-2018
Senior Analyst – Business Development,
2015-2016
Analyst – Business Development, 2013-2014
Led new business unit focused on
evaluating potential adjacent markets
and managing development of new
solutions for MAXIMUS’ $1.2B public
sector health services business segment.
Served on project management team
for 5 new program implementations
and redesigns, with responsibility for
business process modeling, development
of policies and procedures, staff
modeling and production planning,
and leading executive reviews. Managed
pricing, staffing and technology strategy
for 7 state/federal proposals with a
total value of $250M.
Zachary M. Laskin
Washington University in St. Louis, St. Louis, MO
B.S.B.A., Finance, Healthcare Management, 2013
An opportunity to transform the delivery
of healthcare through operational and
technological innovation.
Boston Consulting Group, Summit, NJ
Summer Consultant, Summer 2019
Advised a multi-state payer on a network
optimization strategy to support a
30% claim cost reduction target.
Analyzed hospital and ambulatory
surgical center performance in core
coverage area to determine where
care could be diverted to improve
quality and reduce cost.
Eden Health, New York, NY
Operations Intern, Summer 2018
Supported the Chief of Staff and CEO
on customer acquisition by analyzing
potential commercial customers’ medical
claims to derive potential savings from
improved primary care utilization by
employees.
Pomona Capital, New York, NY
Associate, 2016 – 2018
Managed all aspects of investment
process including industry research,
financial diligence, and investment
committee presentations for $1.75B
AUM private equity secondary fund
investing in other private equity and
venture capital funds.
Citigroup, New York, NY
Analyst/Assistant Vice President,
2014 – 2016
Performed strategic evaluations
of Citi’s businesses and advised on
and executed proprietary Citi M&A
transactions in the North America,
South America and Europe.
Garrett M. Klein
Swanson School of Engineering at the
University of Pittsburgh, Pittsburgh, PA
B.S., Summa Cum Laude, Industrial
Engineering, 2013
An opportunity to improve healthcare
through an investing role.
Newbrook Capital, New York, NY
Hedge Fund Summer Analyst, Summer 2019
Led diligence of investments in consumer
discretionary, consumer staples,
e-commerce, auto parts and cannabis
sectors for a $2B AUM long-short
equity hedge fund with a twelve-year
track record
Advent International, Boston, MA
Private Equity Associate, 2016-2018
Evaluated investments requiring
$250M-$1,000M+ of equity, primarily
in the healthcare sector (services,
pharma, behavioral). Responsibilities
included financial modeling, conducting
company and industry due diligence,
leading financing, accounting and
consulting workstreams, managing
portfolio company operational initiatives
and presenting to investment committee.
Supported 2 portfolio companies
(ATI Physical Therapy and Genoa
Healthcare), including leading a
$780M dividend recapitalization and
a $2B+ sale process. Submitted 2 final
bids, one for a $500M autism services
provider and a second for a $3.5B+
Indian Pharmaceuticals Manufacturer.
McKinsey & Company, Pittsburgh, PA
Business Analyst, Associate Secondee,
2013-2016
Advised clients from multiple industries
on strategic and operational issues;
led due diligence, managed teams and
partnered with senior management
teams. Performed analyses that
informed key business decisions such
as new market entry, private equity
investment decisions, business acquisi-
tions and divestments, salesforce
optimization and R&D portfolio
rationalization.
19
Shuaiqing Liu
University of North Carolina at Chapel Hill,
Chapel Hill, NC
B.S., Magna Cum Laude, Public Health
& Applied Math, 2013
An opportunity to work in a strategic
role in designing innovative healthcare
financing and delivery models through
technology applications
Health IQ, Mountain View, CA
Product Innovation Intern, Summer/Fall 2019
Performed system-wide needs assessment
and successfully identified 4 opportu-
nities to engage with payer, provider,
consultants, and population health
companies in entering the healthcare
space. Created Medicare-related policies
that save up to 42% in premiums for
seniors living a healthy lifestyle.
Worked along the insurance product
cycle from insurer/reinsurer partnership
formulation to sales, marketing, and
operations integration. Product will
launch in over 30 states by end of 2019.
Aon Consulting, San Francisco, CA
Specialist, Analyst, Consultant, Senior
Consultant & Actuary, 2013 - 2018
Led teams of consultants and actuaries
managing 15+ employers’ health &
wellness programs totaling $400M in
annual budget. Worked closely with
various parties in healthcare value
chain, including insurers/TPA, providers,
and population health management
companies to design and price group
health plans. Spearheaded the first
industry study quantifying cost efficiency
of population health programs; receiving
industry recognition Launched Aon
Health’s technology industry vertical
using BI techniques; aims to generate
$13M annual revenue in organic
growth.
Scott H. Lever
Pennsylvania State University, University Park, PA
B.S., Finance, 2012
An opportunity to build, lead and invest
in healthcare services companies that
are embracing the transformation to
value-based care.
Zenyth Partners, Great Neck, NY
Summer Vice President, Summer 2019
Evaluated potential investments in
managed care, specialty physician
services, dental services and healthcare
IT for middle-market healthcare services
private equity firm. Developed and
presented in-depth investment thesis
focused on sub-sectors within the
value-based care ecosystem. Drove
deal process for a potential investment
in a managed care startup, including
developing the financial model,
spearheading due diligence process,
and validating company assumptions.
Independently sourced HCIT investment
opportunities through direct outreach
to founders.
Marwood Group, New York, NY
Vice President, 2014-2018
Analyst, 2012-2014
Led consulting engagements and new
business development activity for a
leading provider of healthcare consulting
and M&A transaction diligence services.
Performed in-depth quantitative and
qualitative private equity due diligence
involving payor reimbursement as well
as market and competitive analysis for
over 100 healthcare services transactions
spanning 50 healthcare sub-sectors.
Launched new consulting division
through development of strategic
partnerships enabling the firm to
underwrite new insurance products
for healthcare M&A deals ranging
from $50M to $1B in enterprise value.
Originally recruited by CEO to serve
as Chief of Staff.
Harrison T. Lee
Princeton University, Princeton, NJ
A.B. Magna Cum Laude, Chemistry, 2015
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to lead and drive strategy
in a healthcare provider system, to
improve the quality and operational
efficiency of care delivery.
Boston Consulting Group, Philadelphia, PA
Summer Consultant, Summer 2019
Advised CIO of a Fortune-500 chemical
company on an affordability PMO for
IT operating costs. Created a financial
model to forecast and create account-
ability for $69M in savings across
multiple service line initiatives and
conducted industry benchmarking
to pressure-test savings targets.
Penn Medicine Center for Health Care
Innovation, Philadelphia, PA
Medical Intern, Summer 2016
Refined the care delivery model for
the Penn Health First Clinic, a technology-
enabled primary care clinic for employ-
ees. Piloted strategies for improving
efficiency in face-to-face physician
visits and performed contextual inquiry
for physician and patient adoption of
virtual visits, finding opportunity in up
to 42% of the clinic’s panel.
United Community Clinic, Philadelphia, PA
Lead Medical Coordinator, 2015-2016
Led >25-person team to run a free
health clinic in West Philadelphia.
Spearheaded quality improvement
projects to increase clinic efficiency
and capacity through workflow opti-
mization, ultimately yielding a 20%
reduction in patient turn-around time.
Won a Penn CAREs grant to establish
a diabetes screening program at the
clinic.
20
Daniel G.
McDonough
Georgetown University, Washington, DC
B.S.F.S., Magna Cum Laude, International
Economics, 2013
An opportunity optimize and help
develop leading healthcare companies
through investment.
Citadel, New York, NY
Surveyor Capital Summer Associate
Summer 2019
Initiated coverage on the Contract
Research Organization (CRO) sector
with investment recommendations for
the sector’s 6 publicly traded companies.
Performed market diligence and
individual company analyses to identify
dislocations between fundamental
equity valuations and consensus
expectations.
GTCR, Chicago, IL
Senior Associate, 2017-2018
Associate, 2015-2017
Evaluated and executed private equity
investments for GTCR’s healthcare
group, which included work that
spanned healthcare’s subsectors.
Developed particular focus on the
life science tools space through four
completed acquisitions and thesis
development work related to genomic
therapeutics and molecular diagnostics.
Managed portfolio companies by
coordinating with senior executives,
attending board meetings, and tracking
core metrics to monitor company
performance.
Credit Suisse, New York, NY
Analyst, 2013-2015
Analyzed and executed mergers,
leveraged buyouts, and recapitalizations
for healthcare corporations and financial
sponsors to support the firm’s healthcare
coverage group. Transaction focused
on the specialty pharmacy space,
which included an acquisition financing
and an initial public offering.
Morgan E. Matthews
Harvard College, Cambridge, MA
A.B., Cum Laude in Field, Human Developmental
and Regenerative Biology, 2014
An opportunity to support the launch
of transformative medicines and drug
development platforms via commercial
or business development roles in
pharmaceuticals and biotech.
TrialSpark, New York,
NYStrategic Partnerships Intern,
Summer 2019
Executed high-impact operations project
ahead of schedule for digital contract
research organization. Mapped patient
scheduling process and built financial
model. Recommended operational
improvements totaling $3M in near-term
savings to senior leadership. Led cross-
functional workshop to drill-down into
proposed solutions, increase firm-wide
visibility and align on go-forward plan.
Ran scientific and commercial due
diligence for potential pharmaceutical
acquisitions.
Putnam Associates, Boston, MA
Consultant, 2017–2018
Senior Associate Consultant, 2016–2017
Associate Consultant I – Associate
Consultant II, 2014–2016
Led diverse project teams through all
stages of pharmaceutical and biotech
client engagement, balancing needs
of internal and external stakeholders.
Drove project thought leadership in
key strategic domains, including: US
and ex-US pricing and payer strategy,
global asset launch preparation, sales
force optimization, defensive counter-
strategies and competitive positioning.
Therapeutic areas span vaccines,
oncology, CNS disorders, autoimmune,
infections and cardiovascular disease.
Brack Lab, MGH, Boston, MA
Research Intern, 2012-2014
Wrote thesis quantifying the temporal
mechanics and asymmetric fate
determinations of muscle stem cells.
Thomas J. Marder
Dartmouth College, Hanover, NH
B.A., Cum Laude, Neuroscience, 2012
An opportunity to support the
development and commercialization of
life sciences innovations in a business
development or strategy role.
Regeneron Pharmaceuticals,
Tarrytown, NY
New Products Planning MBA Intern,
Summer 2019
Developed operational launch plan
for ultra-rare disease asset through
one-on-one meetings and workshop
with over two dozen internal experts
across commercial, medical and R&D
functions. Planned unbranded campaign
focused on improving patients’ and
physicians’ understanding of disease
mechanism.
Putnam Associates, Boston,
MA and San Francisco, CA
Consultant, 2017-2018
Senior Associate Consultant, 2016-2017
Associate Consultant, 2014-2016
Led project teams in executing
commercial and corporate strategy
engagements for leading biopharma-
ceutical companies. Completed over
25 projects, including competitive
landscape assessment, market oppor-
tunity analysis, forecasting, clinical
trial design, and payer contracting
approach.
Joslin Diabetes Center, Boston, MA
Research Assistant, Department of Clinical,
Behavioral, and Outcomes Research,
2012-2014
Completed data collection and statistical
analyses for four-year NIH-funded
study investigating imaging-based
Alzheimer’s disease diagnostics in
patients with diabetes. Published two
scientific manuscripts and contributed
to two funded grant applications
totaling $325,000.
21
Diana C.
Mosquera, M.D.
Stony Brook University, Stony Brook, NY
A.B., Cum Laude, Economics, 2009
Weill Cornell Medicine, New York, NY
M.D., 2014
An opportunity to develop and implement
value-based payment and care redesign
strategies in a healthcare organization
that aims to achieve the quadruple aim.
Penn Medicine, Philadelphia, PA
MBA intern, Office of the CEO
Summer 2019
Reported directly to the VP of
Managed Care while tasked with
analyzing value-based payment strategy
across multiple models and payers.
Assessed financial risk and gain oppor-
tunities across current and upcoming
value-based initiatives. Developed
recommendations based on Penn
Medicine’s strengths, population health
infrastructure and market position.
Penn Medicine, Philadelphia, PA
Attending Physician, 2018- Present
Supervise and train resident physicians
in the specialty of Anesthesiology and
Critical Care in an Academic Medical
Center environment. Member of ACGME
Patient Safety Collaborative to engage
resident physicians in quality improve-
ment. Recruit and select residency
applicants as a member of the Penn
Anesthesiology residency admissions
committee.
Penn Medicine, Philadelphia, PA
Resident Physician, 2014-2018
Developed clinical and procedural
skills necessary to provide anesthetic
care for patients undergoing complex
surgeries at a quaternary hospital.
Managed teams of residents and
CRNAs caring for medically unstable
patients. Developed checklist for safe
care transition of patients arriving in
Post Anesthesia Care Unit.
Elizabeth L. Morse
Dartmouth College, Hanover, NH
B.A., Cum Laude, Biology with Honors, 2015
An opportunity to advance innovations
for personalized medicine, promoting
collaborations to integrate genomic
approaches with drug development to
guide healthcare decisions
Regeneron Pharmaceuticals,
Tarrytown, NY
Business Leadership Development Internship,
New Products Strategy, Summer 2019
Independently developed NSCLC business
case including situational analysis,
revenue model, and marketing playbook.
Collaborated with a cross-functional
team to develop a tactical brand plan.
Led cross-functional tactical workshop
for alignment on scenario planning
and to optimize investment.
Longitude Capital, Greenwich, CT
MBA Intern, Winter/Spring 2019
Developed scientific framework to eval-
uate novel oncology modalities, analyzed
clinical development landscape and
assessed recent deals to monitor current
market landscape. Sourced strategic
investment opportunities for $1.2B
biotech-focused venture capital fund.
ClearView Healthcare Partners,
Newton, MA
Senior Consultant 2018, Consultant 2017-2018
Senior Analyst 2016-2017, Analyst 2015-2016
Biopharma strategy consultant leading
growth strategy projects, including
portfolio prioritization, due diligence,
revenue forecasting, scenario analysis,
and post-merger integration work-
streams. Founded corporate responsi-
bility initiative and chaired Women
Leadership program. Project high-
lights: (1) Analyzed buying process for
CDx platform to prioritize tumor market
segments; (2) Led tumor microenviron-
ment competitive landscape assessment
informing scenario planning and
positioning; and (3) Evaluated
genitourinary pipelines for late-stage
partnership opportunities.
Jennifer Morganroth
University of Pennsylvania, Philadelphia, PA
B.A., Magna Cum Laude, Economics, 2013
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to implement innovative
solutions to improve healthcare delivery
for patients and physicians.
EpilepsyCo, a 4 Catalyzer Company,
New York, NY
Commercial and Clinical Team Lead
(Summer 2019), Consultant (2019- present)
Led clinical and commercial activities
for a Series B start-up creating a non-
invasive epilepsy monitoring device.
Coordinated communication between
the clinical operations and product
engineering teams to ensure that the
software and hardware functionality
of the prototype device met clinical
goals. Conducted interviews with
patients and physicians to inform
product design and user experience.
Department of Neurology, NYU
Langone Medical Center, New York, NY
Research Data Associate, 2013-2014
Developed a primary database for the
concussion research registry and sideline
testing in youth athletes for over 1000
participants, culminating in presenta-
tions and publications. Led education
outreach to develop community-wide
concussion awareness. Selected to
attend The United Nations Concussion
Awareness Summit, an event focused
on the future of concussion policy and
research.
NYU Langone Epilepsy Center,
New York, NY
Research Assistant, Summer 2012
Conducted patient centered outcomes
research to categorize patients with
treatment resistant epilepsy into a
surgical grading scale.
22
Ilana Nelson-Greenberg
Brown University, Providence, RI
B.A., Development Studies, 2010
Bryn Mawr College, Bryn Mawr, PA
Post-Baccalaureate Degree,
Pre-Medical Sciences, 2015
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to integrate clinical
insights with healthcare delivery
systems to bring greater access to
care to underserved populations.
Partners In Health, Haiti/Boston, MA
Haiti Program Coordinator, 2013-2014
Responsible for health program imple-
mentation across 10 clinical sites in
Haiti, with a $40M annual budget,
working with diverse national and
international public/private partners
to execute clinical, operational,
development, communications,
and training programs.
Hopital Universitaire de Mirebalais, Haiti
Project Coordinator, 2012-2013
Led administrative and programmatic
support for executive and leadership
teams, during planning and opening
phases of a 250,000 square foot 300-
bed state of the art teaching hospital
in Mirebalais, which served as a referral
site for 3.4M people, and as a training
program for Haitian residents.
Shining Hope for Communities,
Kibera, Kenya
Health Services Director, Johanna Justin
Jinich Community Clinic, 2010-2011
Helped lead strategic planning and
program development for a new com-
munity health clinic in Kibera, Kenya,
serving over 10,000 patients in its first
year. Hired and supervised a 15 person
staff. Developed clinical, community
health worker and volunteer programs
and oversaw daily clinic operations.
Kristen E. Nehls
Dartmouth College, Hanover, NH
B.A., Magna Cum Laude, Biology, 2014
An opportunity to bring novel
therapeutics to market.
Regeneron Pharmaceuticals,
Tarrytown, NY
MBA Intern in New Products Planning,
Summer 2019
Collaborated with large cross-func-
tional team to develop 2020 strategic
and tactical brand plan for a late stage
therapeutic. Synthesized research and
perspectives from across the organiza-
tion to develop strategic plan and
worked with various stakeholder
groups to gain alignment on path
forward. Conducted in depth competitive
analysis to inform strategy as well as
quantitative analysis to determine the
asset’s market potential.
Oliver Wyman, New York, NY
Engagement Manager, 2018
Associate, 2016-2018
Senior Consultant, 2015-2016
Consultant, 2014-2015
Conducted 10+ strategic and operational
projects across broad industries including:
financial services, logistics manage-
ment, telecommunications and media,
and the fine arts. Primary focus areas
included customer base management
in subscription businesses, specifically
managing customer acquisition, cross
sell and retention through marketing
and sales initiatives. Led teams
of consultants on qualitative and
quantitative analysis, with heavy
use of big data to inform decisions.
Misha
Nasrollahzadeh
Stanford University, Stanford, CA
B.S., Management Science & Engineering, 2013
An opportunity to build technology-
enabled healthcare products, services
and operation models that address
social determinants of health, with
a focus on food-based solutions.
Walmart, Bentonville, AR
Health & Wellness Strategy and Operations
Intern, Summer 2019
Pitched, researched and designed
“GroceryRx” program, an in-store
food-as-medicine offering integrating
Walmart grocery, pharmacy and newly
launched clinic arms. Received leadership
approval to run proof-of-concept in
Fall 2019 in two stores in Georgia.
Castlight Health, San Francisco, CA
Senior Product Manager, 2017-2018
Product Manager, 2016-2017
Launched UI for Castlight Complete
and Anthem Engage, combined plat-
form of healthcare transparency and
wellbeing products for self-insured
employers, accounting for $10M in
Q12018 sales. Led vision and execution
for website redesign, increasing NPS
from -6 to 30. Rebuilt registration and
onboarding for 1M users, reducing call
center volumes by 30%. Served on
committee to integrate Castlight and
acquired company Jiff.
Palantir Technologies, Palo Alto, CA
Deployment Strategist, 2013-2016
Led a team of 8 engineers, designers
and data scientists to build fraud
investigation platform for Fortune 50
health insurance client. Pitched roll-
out strategy to COO, securing first
payor partnership. Designed and exe-
cuted dashboard for clinical trial asso-
ciates to improve patient recruitment
for Fortune 50 pharmaceutical client.
23
Arpan A. Parikh, M.D.
The Ohio State University, Columbus, OH
B.S. with Honors, Biology, Summa Cum Laude,
2011
M.D., 2013
An opportunity to innovate the delivery
of high-quality behavioral healthcare t
o reduce stigma and increase access,
both as a practicing clinician and as an
operational/strategic leader.
CareMore Health, New York, NY
Summer MBA Consultant, Summer 2019
Developed and launched a clinical
workflow streamlining and operation-
alizing the identification and treat-
ment of patients with substance use
disorders in 3 markets serving 20,000
patients. Revised comprehensive
psychiatric medication guidelines for
distribution to all primary care and
behavioral health clinicians.
Icahn School of Medicine at Mount Sinai,
New York, NY
Assistant Professor, Department of
Psychiatry, 2017-Present
Actively practicing, board-certified
psychiatrist treating patients on acute
inpatient psychiatric units across 2
hospitals. Served as Wellness Champion,
identifying areas of critical burden on
trainees and winning $75,000 grant
award to co-lead program implemen-
tation to improve resident wellness
and reduce burn out.
Addiction Institute at Mount Sinai-
St. Luke’s, New York, NY
Medical Director, 2017-2018
Supervised 12-member cross-functional
treatment team and treated patients
suffering from both psychiatric illnesses
and substance use disorders. Revamped
and instituted new referral and
screening process for patients from
both within and outside the Mount
Sinai Health System.
Alomi O. Parikh
Princeton University, Princeton, NJ
B.A., Summa Cum Laude, Chemistry, 2015
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2020
An opportunity to combine insights
from clinical practice with a knowledge
of health care management in order to
improve health care delivery systems.
McKinsey & Company, Jersey City, NJ
Summer Associate, Summer 2019
Advised global pharmaceutical company
on assessment and prioritization of all
opportunities in the R&D pipeline.
Provided deep dives on target disease
areas and led working sessions with
R&D client teams. Built and maintained
a database of qualitative assessments
of each opportunity. Facilitated final
data delivery and visualization to aid
decision-making at the senior level.
Perelman School of Medicine at the
University of Pennsylvania,
Philadelphia, PA
Research Intern, 2016-2019
Designed and implemented multiple
quality improvement projects in
departments at University of
Pennsylvania hospitals as part of
multidisciplinary teams, including a
pathway to reduce time to seizure
treatment and a tool to improve
follow up in patients at high risk of
vision loss. Conducted research in neu-
rology and pediatric ophthalmology
that have resulted in peer-reviewed
publications and national presentations.
Natalie E. Pancer
Yale University, New Haven, CT
B.S., Biomedical Engineering, 2014
An opportunity to work in strategy and
business operations at the intersection of
life science and technology innovation.
PicnicHealth, San Francisco, CA
Partnerships/Strategy Intern, Summer 2019
Designed two IRB-approved real world
evidence studies, and product managed
launch across engineering, design, and
partnerships teams. Led company lead-
ership through analysis and discussion
of new business development strategy,
leading to outreach of new potential
biopharmaceutical partners.
Pfizer, New York, NY
Consulting & Execution Manager
(2017-2018), Analyst (2015-2017)
Led strategy and operational improve-
ment projects approved by the CEO
or executive team across research,
development, and commercial functions.
Partnered with internal clients to
define their business challenge,
develop solutions, and implement
recommendations. Primary focus areas
included clinical development and
innovation.
Beghou Consulting, New York, NY
Analyst, 2014-2015
Built sales and marketing Tableau
dashboards utilized by brand teams at
major biopharmaceutical companies.
Worked with clients to understand
sales analyses needed and wrote SAS
and SQL code to develop sales reports.
24
Jason R. Peterson
jason.peterson@[email protected]
Yale University, New Haven, CT
B.A., History and pre-medical studies, 2008
Columbia University, New York, NY
Master of Public Health, 2011
School of Engineering and Applied Sciences at
the University of Pennsylvania, Philadelphia, PA
Master of Computer & Information Technology,
2020
An opportunity to develop and invest
in premier healthcare organizations.
Capital Group, Los Angeles, CA
Summer Investment Analyst, Summer 2019
Researched and recommended equity
investments with a focus on multi-year
risks and opportunities.
Roivant Sciences, New York, NY
Technology Investment & Innovation
Associate, 2017–2018
Co-founded corporate venture capital
practice investing in Series A–C health-
care technology companies. Sourced,
diligenced and executed company’s
first investment as lead investor in
$5M Series A financing. Implemented
“drug+digital development” program
where drugs were developed alongside
synergistic technology, leading to
$110M in technology partnering
opportunities.
Texas Medical Center, Houston TX
Biodesign Innovation Fellow, 2015-2016
Co-founded digital health company
developing H.R. software for 100-
nurse E.R. unit at world’s largest
children’s hospital.
Oppenheimer New York, NY
Associate Director, 2014–2015
Generated investment recommendations
across medical device, healthcare
technology, distribution, labs, tools
and diagnostics companies.
BlackRock, New York, NY
Portfolio Management Analyst, 2011–2014
Collaborated with portfolio managers
to manage $60B in assets for endow-
ments and pensions. Generated three
executed trades.
Parth D. Patel, D.M.D.
University of Miami, Coral Gables, FL
B.A., Cum Laude, Economics, 2014
University of Pennsylvania School of Dental
Medicine, Philadelphia, PA
D.M.D., 2018
Scale a multi-specialty dental services
company that delivers high-quality
clinical outcomes, a consumer-focused
experience and lasting societal impact.
Smile Culture Management,
Philadelphia, PA
Co-Founder and CEO, 2015-Present
Furthered growth of Smile Culture, a
multi-specialty dental support organi-
zation. Executed multiple transactions
for platform acquisition, launched
second de novo location and developed
centralized infrastructure to support
platform growth. Currently lead a
team across 6 Greater Philadelphia
locations, including 25 doctors and
spearhead dual-growth strategies in
M&A and de novo builds. Smile Culture
is on pace to treat over 35,000 patients
in 2019.
University of Pennsylvania School of
Dental Medicine, Philadelphia, PA
Doctor of Dental Medicine Candidate,
2014-2018
Completed doctorate program across
four years, including delivering care
within clinical units and completing
6 rotations. Rotations included: Oral
and Maxillofacial Surgery, Orthodontics,
Periodontics, Pedodontics, Radiology
and Endodontics. Awarded Penn
Dental Medicine’s Deans Scholarship
and attended externships at King’s
College in London and Tokyo Medical
and Dental University.
Niyoshi P. Patel
University of Pennsylvania, Philadelphia, PA
B.S., Magna Cum Laude, Economics, 2012
B.A., Magna Cum Laude, Biology, 2012
An opportunity to build biotechnology
companies developing groundbreaking
therapies
bluebird bio, Cambridge, MA
Business Development MBA Intern,
Summer 2019
Developed and presented a cell therapy
landscape overview to key leadership;
Created a model to understand economic
implications of third-party obligations
for new products in development
Purdue Pharma, Stamford, CT
Senior Manager, Business Development
& Finance, 2016-2018
Worked with team of investment
professionals and executive manage-
ment to diligence and complete
various acquisitions and collaborations;
Co-led the financial modeling,
structuring, and negotiations for
a co-commercialization agreement
on Symproic (treatment for opioid
induced constipation)
Athyrium Capital, New York, NY
Analyst, 2014-2016
Completed all aspects of diligence,
financial modeling, execution, and
management of investments for the
healthcare-focused fund; Independently
sourced Clover Health as Athyrium’s
first healthcare IT investment (led to
a successful exit for Athyrium)
Great Point Partners, Greenwich, CT
Analyst, 2012-2014
Completed all aspects of diligence,
financial modeling, execution, and
management of investments for the
healthcare services-focused fund;
Independently sourced Softbox
Systems as Great Point’s first ex-US
investment
25
Ying Ying Shi, CFA
University of San Simon, Cochabamba, Bolivia
B.A., Economics, 2010
EDHEC Business School, Nice, France
M.Sc., Finance, 2012
An opportunity to lead a pharmaceutical
company on its road to deliver innovative
drugs and meet the evolving needs of
patients worldwide.
Novartis, East Hanover, NJ
Summer Finance Associate, Summer 2019
Created a dynamic dashboard that
enabled monitoring of wholesaler and
specialty pharmacy’s inventory levels
and automated calculations of related
financial metrics. Leveraged momentum
and advanced finance team’s digital
journey on further analyses, e.g.
marketing expenses and price-volume
effects. Trained consultants and other
MBA interns.
Accenture Strategy, Munich, Germany
Manager, 2018
Consultant, 2015-2018
Led health care client teams in mergers
and acquisitions projects, including a
EUR 1B pharmaceutical divestiture
project and a health care services
company’s Transitional Service
Agreement exit in 76 countries in
Emerging Markets.
Clueda AG, Munich, Germany
Chief Organization Manager, 2014-2015
Advised CEO through preparation of
company transaction, with ultimate
merger by absorption into Baader
Bank AG.
Alira Health, Munich, Germany
Project Manager, 2012-2014
Managed 10+ health care mergers
and acquisitions projects across 7
international offices, overseeing end-
to-end project pipeline from market
research, preparation of long and
short lists, target approach and due
diligence. Created private equity
database to streamline health care
investor search.
Lora Rosenblum
University of Pennsylvania, Philadelphia, PA
B.A., Cum Laude with Distinction, Health
& Societies, 2012
An opportunity to scale patient outcomes
and provider solutions by joining a
business development or growth strategy
team within a technology-enabled
healthcare organization.
Cedar, New York, NY
Business Development, Summer 2019
Designed go-to-market strategy for
new business line. Ran and won RFP
process for company’s first joint payer/
provider deal. Developed contract
language for new product offering.
Flatiron Health, New York, NY
Operational Excellence Manager, 2016-2018
Led internal initiatives to drive
enhancements in company’s oncology-
specific software. Ran strategic
program for clients to achieve bonus
reimbursements through federal
initiative that rewards providers
based on clinical outcomes. Managed
communication for entire physician
network after announcement of Roche
acquisition.
Oscar Insurance, New York, NY
Service Operations Lead, 2015-2016
Claims & Benefits Specialist, 2015
Customer Service Representative, 2014-2015
Built and led five-person team to
resolve high-priority member issues
such as urgent pharmacy transactions,
pre-visit benefit clarifications, network
complaints and denied claims. Scaled
team processes to ensure consistent
service levels each year. Managed
national complaints department,
supporting 145,000 members in four
operating states.
Wells Fargo, Philadelphia, PA
Financial Analyst, Healthcare Financial
Services, 2012-2014
Evaluated financial statements of
healthcare systems with over $500M
in annual revenue.
William P. C. Rice
Northwestern University, Evanston, IL
B.A., Cum Laude, Economics, 2015
An opportunity to lead operations and
strategy in a healthcare organization or
medical device company
McKinsey and Company, Charlotte, NC
Summer Associate, Summer 2019
Senior Business Analyst, 2017-2018
Business Analyst, 2015-2017
Consulted multibillion dollar companies
on a range of strategic and operational
topics. A highlighted selection includes:
advising multiple hospitals on cost
reducing strategies (e.g., identifying
margin negative procedures and ratio-
nalizing supply chain spend), advising
private equity firms on the suitability
and size of niche pharmaceutical
markets, advising insurance companies
on how to revamp their customer
experience and digital strategies,
advising hospitals on how to make
a seamless patient experience, and
advising two fortune 100 companies
on potential cost synergies that could
be achieved from a merger.
26
Rishi Taggarsi
University of California, Berkeley; Berkeley, CA
B.A., Political Economy, 2013
An opportunity to launch and scale
products in a dynamic healthcare tech-
nology organization that improves the
quality and accessibility of patient care
Teladoc, New York, NY
Product Strategy Intern, Summer 2019
Led development of business case for
a new “Virtual Primary Care” offering,
including product definition, market
validation, clinical/operational risks &
mitigation plan, partnership strategy,
pricing and detailed financial forecasts.
Presented recommendations to full
C-suite and senior leadership that
crafted positioning for upcoming
product launch.
CipherHealth, New York, NY
Strategy & Analytics Lead, 2017-2018
Recommended operational improve-
ments on patient rounding to senior
leadership at 14 health systems. Led
team of data scientists to conduct
complex analysis on patient-level
clinical outcomes data. Results at one
major health system showed 16.3%
decrease in readmissions and 440
identified patient issues.
L.E.K. Consulting, San Francisco,
CA and London, UK
International Associate Consultant, 2016-2017
Associate Consultant, 2015-2016
Associate, 2013-2015
Evaluated Medicaid behavioral health
market opportunity in 24 U.S. states
for national payer; built pricing model
used to pitch and close $172M funding
of digital health startup; quantified
market size for 5 digital health segments
and recommended 8 startups for $20M
investment by large VC fund. Awarded
Consulting Magazine’s Excellence in
Social & Community Investment for
pro bono work for nonprofit hospice
provider.
Evan M. Strother
Duke University, Durham, NC
B.S., Magna Cum Laude, Civil Engineering,
2013
A opportunity to build businesses that
innovate in the US health care system.
LLR Partners, Philadelphia, PA
MBA Investment Intern, Health Care Private
Equity, Summer 2019
Closed growth investment from $1.2B
fund in employee benefit technology
business. Developed firm-wide invest-
ment thesis and strategy for healthcare
payer technology sector.
FFL Partners, San Francisco, CA
Operating Associate, Private Equity,
2017-2018
Worked with portfolio companies in
$2.0B fund on board-level strategic
initiatives. Example projects include:
(1) Building acquisition/de-novo
growth strategy and financial model
for Autism services businesses. (2)
Developing product, go-to-market
and pricing strategy for a health
care worker training business’s
first digitally-delivered solution.
Google, Inc, San Bruno, CA
YouTube Product Specialist, 2016-2017
Led product and operational initiatives
to improve YouTube for over >1.8B
monthly viewers. Example project
includes designing and launching
video reporting feature, which trains
machine learning algorithms to
remove 30,000+ offensive videos
per month.
McKinsey & Company, Atlanta, GA
Senior Business Analyst, 2013-2016
Executed critical strategy and operational
initiatives for C-suite executives. Example
projects include: (1) Facilitating creation
of joint venture that provides cyberse-
curity services to 150+ health care
companies. (2) Performing strategic
due diligence of mega-merger of two
top 10 tech companies.
Romana Sohail, F.S.A.
Lahore University of Management Sciences,
Lahore, Pakistan
B.S., Mathematics, 2013
An opportunity to identify and build
successful healthcare businesses
through a private equity investing role
Evercore Partners, New York, NY
M&A Advisory Summer Associate,
Summer 2019
Conducted financial analysis, due
diligence, and M&A focused materials
development across clients in the
healthcare, technology, and fintech
sectors
AXA – Global Healthcare, Singapore
Manager, New Business Underwriting,
2015-2018
Evaluated 100+ investment opportunities
in healthcare and insurance sectors;
built multi-scenario operating models,
conducted valuation analyses, and
managed third-party advisors.
Managed team of 3 associates and
analysts to synthesize findings and
debrief senior team members.
Prepared diligence question lists and
led diligence calls with management
of potential acquisition targets on
targeted topics, including organization
structure, competition, industry,
financials, sales and marketing and
products
Mercer, Singapore
Consulting Senior Analyst, 2014-2015
Only Senior Analyst selected for client
secondment, during the challenging
period of PayPal’s spinoff from eBay.
Negotiated eBay’s post-spin off health
insurance contracts, worth $2.1M, in
11 countries delivering 10% savings
Supported Asia Consulting Leader in
development of Asia’s 1st analytics-
based employee benefits model.
Oversaw model implementation
for 40,000 employees in Philippines,
leading to 10% annual cost savings
27
Shilpa Topudurti
University of Rochester, Rochester, NY
B.S., Cum Laude, Molecular Genetics, 2014
London School of Economics, UK
M.Sc., International Health Policy, 2015
An opportunity to improve patient
access to novel therapeutics by
strengthening collaboration between
life sciences and providers
Genentech, South San Francisco, CA
Commercial Summer Associate,
Summer 2019
Created financial decision maker
targeted non-personal promotion
strategy for hematology/oncology
product. Managed creative agencies
during asset creation for product
launch. Leveraged data analytics to
assess medication monitoring infrastruc-
ture capabilities at health systems in
order to develop solutions to improve
patient access.
The Advisory Board Company (ABCO),
Washington, DC
Manager, Corporate Strategy
& New Product Development, 2016-2018
Served as Chief of Staff to the CPO,
overseeing the successful technology
product portfolio integration during
Optum’s acquisition of ABCO. Provided
near-term vision and strategy to chief
officers and board. Led concept design
and testing for launch of clinical
decision support and post-acute care
provider technologies.
McKinsey & Company, London, UK
Analyst, 2015-2016
Specialized in the pharmaceuticals
and medical products practice. Project
highlights: (1) Worked with top-5
biopharma client to integrate out-
comes-based health business models
to improve market access (2)
Developed technology tool to assess
client readiness for global biopharma
launches; (3) Supported $20B company
in commercial growth roadmap
strategy in neurology.
Aaron J. Thomas
Brigham Young University, Provo, UT
B.S., Summa Cum Laude, Business
Management, 2012
An opportunity to lead within a mission-
driven healthcare company building or
scaling transformative models of care
delivery or payment.
Eleanor Health, Waltham, MA
Strategy and Operations Intern,
Summer 2019
Wrote a $2M proposal to deliver
substance use disorder treatment and
recovery services for a state Medicaid
program. Researched and created
pitch deck materials outlining the ROI
of Eleanor Health’s care model vs.
existing care models. Developed
materials for and attended company’s
first board meeting. Led creation and
implementation of company’s first
information security and privacy policies.
Cohen Private Ventures, New York, NY
Private Equity Associate, 2016-2018
Monitored existing and executed new
private equity, growth and venture
capital investments for a $10B+ family
office. Executed CPV’s first venture
capital investments and helped institu-
tionalize the firm’s approach to venture
investing. Trained 2 private equity
associates on quarterly reporting
processes and monitoring 10 portfolio
companies.
Goldman, Sachs & Co., New York, NY
Investment Banking Analyst & Associate,
2013-2016
Advised natural resources companies
through merger, acquisition, and capital
raising opportunities. Developed
expertise in precedent transaction,
discounted cash flow, LBO, and
accretion / dilution analyses.
Jennifer J. Thornton
Massachusetts Institute of Technology,
Cambridge, MA
B.S., Biological Engineering, 2015
An opportunity to improve health care
by bringing innovative new therapies
to patients.
Blueprint Medicines, Cambridge, MA
Commercial MBA Intern, Summer 2019
Established market development
strategy and tactical path forward for
an investigational precision therapy in
oncology. Assisted in early-stage brand
planning efforts including marketing
agency selection and brand vision.
Facilitated a complex clinical trial
decision through creation of a decision
framework and collaboration with clin-
ical, medical, regulatory and commercial
stakeholders; resulted in core team
agreement and recommendation
brought to the executive team.
Boston Consulting Group, Boston, MA
Consultant, 2017-2018
Associate, 2015-2017
Partnered with clients across health-
care and other industries on strategic
and operational consulting engage-
ments. Conducted 10 due diligences
to inform private equity investments
from medical devices to biometric
security. Led post-merger integration
of R&D and HR departments for l
eading pharmaceutical companies.
Analyzed historical global health
product launches for a philanthropic
foundation. Developed manufacturing
site investment strategy for a generic
pharmaceutical company.
28
Sarah R. Weber
Williams College, Williamstown, MA
B.A., Psychology & Neuroscience, 2011
Invest with integrity in the next
generation of biopharma companies.
Nantahala Capital, New Canaan, CT
Healthcare Equity Analyst, Summer 2019
Analyzed healthcare public equities
for a long/short hedge fund. Focused
primarily on biotech, including gene
therapy, rare disease, oncology, and
microbiome. Performed due diligence
and valuation work on existing
investments and pitched new ideas
to the investment team.
Piper Jaffray & Co., New York, NY
Assistant Vice President, Sell-Side Equity
Research, 2017-2018
Analyst, Sell-Side Equity Research,
2015-2017
Recommended 31 SMID cap biotech-
nology stocks. Built and updated
financial models, including valuation
by DCF, NPV, comparable company
analysis. Analyzed business models
and market potential of pipeline
assets, focusing on clinical diligence
(physician surveys, physician calls,
medical conferences) to differentiate
stock recommendations.
Marketing Evolution, New York, NY
Senior Research Analyst, 2013-2014
Research Analyst, 2013-2014
Analyzed success of direct-to-consumer
pharma marketing campaigns and
devised strategies to improve return
on investment from pharma marketing
spend.
Boston Children’s Hospital, Boston, MA
Clinical Research Coordinator, 2011-2013
Oversaw operations of five clinical
studies in Crohn’s Disease and
Ulcerative Colitis. Recruited patients
to trials, performed medical chart
reviews, collected biological samples,
and analyzed data in SPSS.
.
David X. Wang
Duke University, Durham, NC
B.S., Summa Cum Laude, with Distinction,
Economics, 2014
An opportunity to identify, grow and
transform healthcare or technology
businesses through equity investing
or business development roles.
Cornell Capital, New York, NY
Private Equity MBA Intern, Summer 2019
Assessed control investments across
healthcare, business and financial
services, and consumer industries at
$3B AUM, cross-border U.S./Asia fund.
Led diligence of professional employer
organization and sourced 2 potential
investment partners.
MSD Partners, New York, NY
Private Equity Associate, 2016-2018
Evaluated control leveraged buyout
and structured investments for
Michael Dell’s $15B family office.
Invested in Ring Container (packaging)
and WCG (clinical trial services).
Developed views on ~50 investments
across multiple industries, managed
deal and diligence workstreams,
coordinated external advisors and
built extensive 3-statement operating
models. Conducted outreach in pursuit
of annual investment themes and
generated one-on-one meetings
with businesses.
Morgan Stanley, New York, NY
Investment Banking Analyst, Healthcare,
2015-2016
Executed debt, equity, and M&A
transactions; counseled clients on
corporate strategy. Deals included
AmerisourceBergen’s acquisition of
PharMEDium from CD&R and Sagent
Pharmaceuticals’ sale to Nichi-Iko.
Jefferies, New York, NY
Investment Banking Analyst, Healthcare,
2014-2015
Advised clients on M&A and financing.
Deals included Seahorse Biosciences’
sale to Agilent and Pernix’s acquisition
of Zohydro.
An opportunity to work with a dynamic,
mission-driven team to build and develop
healthcare delivery organizations.
OptumCare, Eden Prairie, MN
Delivery Strategy Intern, Summer 2019
Designed implementation plan on
behalf of care delivery organization
COO to improve primary care and
housing access for 225,000 Medicaid
patients. Developed payer, provider
and local community partnering strat-
egy needed to execute initiatives,
projected to reduce average care
costs 44% per member per month via
improved housing enrollment and home-
less outreach processes, new tenancy
support services and redesigned
primary care models. Built data
infrastructure to enable ROI determi-
nation for program investments.
MaineHealth, Portland, ME
System Development Manager, 2016-2018
System Development Business Analyst,
2015-2016
Led initiatives on behalf of EVP to
advance strategy and operations for
$3B, 10-hospital delivery system
serving 70% of Maine’s population,
regularly collaborating with system
and hospital leadership. Implemented
operational benchmarking tool in 450
hospital and practice departments.
Consulted with community hospital
CFO to achieve $1.6M budgeted
savings via staffing model and supply
chain redesigns. Supported General
Counsel and Trustees in due diligence
process for merger of 10 local
members into single corporate entity.
Managed all-payer claims database
used guide COO’s system expansion
efforts based on service leakage and
growth analyses.
Nina Underman
Bowdoin College, Brunswick, ME
B.A., Neuroscience, 2015
29
Schuyler D. Yost
Colgate University, Hamilton, NY
B.A., English, 2011
An opportunity to leverage technology
to improve the consumer experience in
health care.
McKinsey & Company, Boston, MA
Summer Associate (People Analytics),
Summer 2019
Assessed implications of major organi-
zational restructuring following a
healthcare services client’s acquisition
of a health insurance company.
Translated a telecommunications
client’s future business priorities to
talent needs and developed recom-
mendations to bridge emergent talent
gap through hiring, acquihiring, and
upskilling existing employees.
Centers for Medicare and Medicaid
Services, Baltimore, MD
Senior Advisor (CMMI), Summer 2018
Developed proactive talent acquisition
strategy and built a performance
management system for the Center
for Medicare and Medicaid Innovation.
Recruited new Chief Medical Officer
and other key hires.
Quartet Health, New York, NY
Chief People Officer / Founding Team
Member, 2015–2018
Established and led the Human
Resources and Recruiting functions for
the company. Led team of 6 to recruit
and onboard 210 full-time employees.
Served as a member of the executive
team and presented to Board and
Investors from Google Ventures and
Oak HC/FT at quarterly Board
Meetings.
Oxeon Partners, New York, NY
Co-Founder, Senior Associate, 2011-2015
Partnered with Co-Founder / CEO to
define business model, values, and
strategy. Built management teams
for leading healthcare technology
and services companies.
Daichen Wei
University of California Berkeley, Berkeley, CA
B.A. Economics, 2012
An opportunity to transform patient
care and to improve patient access
through commercialization of innovative
therapeutics.
The Janssen Pharmaceutical Companies
of Johnson & Johnson, Horsham, PA
Brand Marketing Summer Associate,
Summer 2019
Developed personal and non-personal
now approved assets, including firsts
for immunology, to communicate
approval of new indication at launch
across prioritized stakeholders;
Managed three internal and external
agencies and collaborated with six
cross functional teams to incorporate
now approved campaign assets within
omni-channel tactical plan and launch
communication plan
KPMG, San Francisco, CA
Senior Associate 2014 – 2016
Associate 2012 – 2014
Developed Medicaid pricing strategies
for multi-billion dollar pharmaceutical
company during client and competitor
product launches; pricing strategy
helped client secure approval and
maintain market share; Established
multi-billion dollar life sciences
manufacturer’s operating procedure
for compliance with National Physician
Payment Transparency Program by
analyzing millions of data points to
identify reportable transactions of
compensation to doctors/hospitals
to promote products
Richard E. Woo
Rice University, Houston, TX
B.A., Mathematical Economic Analysis, 2013
An opportunity to lead strategy at
a life sciences company in a business
development role or as an investor.
Gilead Sciences, Foster City, CA
Corporate Development Summer Associate,
Summer 2019
Conducted in-depth diligence, market
research and financial analyses for
potential partnerships, licensing, acqui-
sitions and investment opportunities.
Assisted in restructuring of European
filgotinib commercial partnership as
part of broader $5.5B R&D collaboration
with Galapagos.
Amgen, Thousand Oaks, CA
Strategic Planning and Operations Manager,
2017-2018
Gathered, analyzed and reported
organizational performance analytics
for the Devices and Final Drug Product
Technologies department. Managed
resource forecasting and development
timelines for drug delivery platforms
across Amgen’s product portfolio.
HealthCor Partners Management,
New York, NY
Investment Associate, 2015-2017
Sourced and evaluated new investment
opportunities for $400M AUM late-stage
venture healthcare fund across medical
devices, biopharmaceuticals and digital
health. Reviewed and evaluated
company performance, provided
advice and built financial analyses
for existing portfolio companies.
J.P. Morgan, San Francisco, CA
Investment Banking Analyst, 2013-2015
Primary healthcare coverage analyst
on 14 announced deals with a combined
transaction size of over $60B, including
equity offerings, M&A advisory, con-
vertible debt offerings for biopharma-
ceutical and medical device companies.
Built discounted cash flow, leveraged
buyout, accretion/dilution, and tax
inversion models.
3030
The following organizations provided
internships for Health Care Management
Students in Summer, 2019.
4CATALZYER
Guilford, CT or New York, NY
ACCENTURE STRATEGY
New York, NY
BAIN AND COMPANY
San Francisco, CA
BCG
Atlanta, GA
Summit, NJ
Philadelphia, PA
BLACKSTONE
New York, NY
BLUEBIRD BIO
Boston, MA
BLUEPRINT MEDICINES
Cambridge, MA
BOSTON SCIENTIFIC
Maple Grove, MN
BUTTERNUT BOX
London, UK
CAPITAL GROUP
Los Angeles, CA
CAREMORE
New York, NY
CEDAR
New York, NY
CERNER CORPORATION
Kansas City, MI
CHC SOLUTIONS
New York, NY
CITADEL - SURVEYOR CAPITAL
New York, NY
CITYBLOCK
New York, NY
COMMODORE CAPITAL
New York, NY
DAVITA
Denver, CO
EDEN HEALTH
New York, NY
ELEANOR HEALTH
Boston, MA
EVERCORE
New York, NY
GATES FOUNDATION
Seattle, WA
GENENTECH
South San Francisco, CA
GILEAD
Foster City, CA
GOLDMAN SACHS
New York, NY
GSK
Philadelphia, PA
HEALTH IQ
Mountain View, CA
HUMANA
Louisville, KY
INDIAN HEALTH SERVICES
Shiprock, NM
J.P. MORGAN
New York, NY
JANSSEN PHARMACEUTICALS
Philadelphia, PA
JOHNSON & JOHNSON
San Francisco, CA
LLR PARTNERS
Philadelphia, PA
MAGENTA THERAPEUTICS
Cambridge, MA
MANATT, PHELPS AND PHILLIPS
New York, NY
MARSHALL WACE
New York, NY
MCKINSEY & COMPANY
Jersey City, NJ
Charlotte, NC
Waltham, MA
Philadelphia, PA
MILLIMAN HEALTHCARE
Greater China
NANTAHALA CAPITAL MANAGEMENT
Darien, CT
NEW MOUNTAIN CAPITAL
New York, NY
NEWBROOK CAPITAL
New York, NY
NOVARTIS PHARMACEUTICALS
East Hanover, NJ
OLIVER WYMAN
New York, NY
PFIZER, INC.
New York, NY
PICNICHEALTH
San Francisco, CA
POST CAPITAL PARTNERS
New York, NY
QED THERAPEUTICS
San Francisco, CA
REGENERON PHARMACEUTICALS
Tarrytown, NY
SMILE CULTURE MANAGEMENT
Philadelphia, PA
SYNOVIUM
Philadelphia, PA
Internship Sponsors
2019
31
TELADOC
New York, NY
TRIALSPARK
New York, NY
UnitedHealth Group
Eden Prairie, MN
Minneapolis, MN
UNIVERSITY OF PENNSYLVANIA
HEALTH SYSTEM
Philadelphia, PA
VARIAN MEDICAL
San Francisco, CA
WALMART
Bentonville, AR
WATERMARK
New York, NY
ZENYTH PARTNERS
Great Neck, NY
32
Mentors are leaders and senior managers
in the health care field who have agreed
to provide career and professional
development advice and guidance to
Health Care management students.
IMAN ABUZEID, M.D.
CEO and Co-Founder
Incredible Health, Inc.
San Francisco, CA
MATT ADKINS
Director, Corporate Strategy
Humana
Louisville, KY
ANIMESH AGARWAL
Sr. Manager
Intrexon Corporation
S. San Francisco, CA
AMEYA AGGE
Managing Director
BlueMountain Capital
New York, NY
JESSICA AISENBREY
Director, Performance Improvement
Boston Medical Center
Boston, MA
DAVID ALLEN
Director, Business Development and
Licensing
Medtronic
Minneapolis, MN
MARK ARPELS AMEZ-DROZ
Principal Associate, Corporate Development
Medtronic
Minneapolis, MN
VICTORIA GOLDIN ATENCIO
Marketing Director of Value Based
Partnerships
Amgen
Thousand Oaks, CA
KAREEN BACINSKI
Director, Business Development
DePuy Synthes,
a Johnson & Johnson Company
Flemington, NJ
DAVID BAIADA
CEO
Bayada Home Health Care
Moorestown, NJ
GEOF BAKER
CEO & Managing Director
VenAdvisory
Seattle, WA
VIKRAM BAKHRU, M.D.
Chief Operating Officer
ConsejoSano, Inc.
North Hollywood, CA
NEIL E. BANSAL
Vice President of Business Development
Pharmscript
New York, NY
ANDREW BARNELL
Chief Executive Officer
Geneoscopy LLC
St. Louis, MO
SIMON BASSEYN, M.D.
Biotech Analyst
Ghost Tree Capital
New York, NY
JAMIL M. BEG
Principal
5AM Ventures
Boston, MA
ALI BEHBAHANI, M.D.
General Partner
New Enterprise Associates, Inc.
Chevy Chase, MD
ERIC BELL
Managing Director
SpringRock Centures
Seattle, WA
GRACE BELL
Director of Strategic Initiatives
& Specialty Operations
CareMore Health
Los Angeles, CA
RYAN BERGER
Sr. Director of Product Development
Zynx Health, a division of Hearst
Corporation
Los Angeles, CA
ALEXIS BERNSTEIN
Sr. Director, Client Services
Wellframe
Boston, MA
NIKHIL BHOJWANI
Managing Partner
Recon Strategy
Cambridge, MA
DARREN M. BLACK
Managing Director
Summit Partners L.P.
Boston, MA
DAVID S. BLOCK, M.D.
President
Gliknik Inc.
Baltimore, MD
KARA BROTEMARKLE
International Business Leader
Roche / Genentech
Basel, Switzerland
LUCAS BUCHANAN
Chief Financial Officer
Silk Road Medical
Sunnyvale, CA
ELENA CASTAÑEDA
Senior Director
Optum
New York, NY
ELIZABETH CELATA
Principal
The Boston Consulting Group
Philadelphia, PA
ALLI CHANDRA
Senior Manager
AVIA
Chicago, IL
DUSTIN WM CHANG
Analyst
Balyasny Assessment L.P.
New York, NY
SARBANI CHAUDHURI
Global Commercial Franchise Head:
Neuromuscular Franchise,
Pfizer Rare Diseases
Pfizer Inc.
New York, NY
CHRISTOPHER P. CHEN
Medical Director Value Management,
Associate Medical Director Hospitalists
UW Medicine, Valley Medical Center
Seattle, WA
GEORGE Z. CHEN, M.D.
SVP and Head of China Development Unit,
AstraZeneca Global Medicines Development
AstraZeneca
Shanghai, China
KELLY CHENG
Head of New Market Strategy
Honor
San Francisco, CA
MARK CHIN
Investment Director
Arix Bioscience
New York, NY
Health Care Program Mentors
2019
33
BRIAN G. CHOI, M.D.
Chief Medical Information Officer;
Professor of Medicine & Radiology
The George Washington University
Washington, DC
JIGAR CHOKSEY
Analyst
Highline Capital
New York, NY
BRETT CHUNG
Head of Product
RDMD
San Francisco, CA
EDDIE CISNEROS
Executive Coach
Inspirate
Schaumburg, IL
RYAN COCHRAN
Chief Financial Officer
One Homecare Solutions
Miami, FL
SOLOMON COLE
Vice President
AB Private Credit Investors
(AllianceBernstein)
Austin, TX
DAVID COLLIER
CEO
Velocity Pharmaceutical Development
And Presidio Partners
South San Francisco, CA
TERI CONDON
Vice President,
Strategy and Business Development
QuantiaMD, a Sub of Physician’s Interactive
Waltha, MA
EMILIE COUEIGNOUX
Associate Director, Business Development
Seattle Genetics
Bothell, WA
MICHAEL CROMWELL
VP of Strategic Development
MDVIP
Boca Raton, FL
KENNETH CUSTER
Senior Director
Portfolio Strategy and Decision Sciences
Eli Lilly
Zionsville, IN
PITAMBER DEVGON, M.D.
Chief Medical Officer, Co-Founder
Velano Vascular, Inc.
Philadelphia, PA
TANIA D. DIMITROVA
Chief Business Officer
Artios
New York, NY
AUSTIN DIXON, M.D.
Fellow Physician, Department of Radiology
Duke University Medical Center
Durham, NC
BENJAMIN DORANZ, PH.D.
President and CEO
Integral Molecular, Inc.
Philadelphia, PA
CATHY DUREI
President/Founder
Rumbly Health
Rye, NY
TED EBEL
Chief Business Officer
Colorescience, Inc.
Carlsbad, CA
BRANDON EINSTEIN, M.D.
Vice President
Enhanced Healthcare Partners
New York, NY
RAMI ELGHANDOUR
Former President and CEO
Nevro
Redwood City, CA
MYRIAM EXUMÉ
Director, Regional Marketing
Merck
North Wales, PA
DANIEL FAGA
Chief Business Officer
Spark Therapeutics
Philadelphia, PA
JEFFREY FIORE
Associate Director, Strategy
Teladoc Health
New York, NY
TOMMY FU, M.D.
Emergency Medicine Physician
Lahey Hospital and Medical Center
Burlington, MA
STEPHANIE GAMPPER
Director
Cedars-Sinai Health System
Beverly Hills, CA
MRIDUL GANESH
Chief Product Officer
Laudio
Cambridge, MA
DAN GEOFFRION
Marketing Manager
Medtronic
Minneapolis, MN
NAVID GHARAVI
Vice President
RLH Equity
Los Angeles, CA
SEAN GLEESON, M.D.
President
Partners For Kids, Nationwide Children’s
Hospital
Columbus, OH
JONATHAN GODIN, M.D.
Assistant Professor, Orthopaedic Surgery
Virginia Tech Carilion Clinic
Roanoke, VA
NOAH GOODMAN
Director, Business Development
Seres Therapeutics
Cambridge, MA
GARY L. GOTTLIEB, M.D.
Former Chief Executive Officer
Partners In Health
Boston, MA
VIKAS GOYAL
Principal
SR One
Cambridge, MA
TODD GUREN
Director
Regence BlueCross BlueShield
Portland, OR
LOVISA GUSTAFSSON
Assistant VP
The Commonwealth Fund
New York, NY
PHILIP P. GUTRY
Chief Business Officer
Kronos Bio
San Mateo, CA
(JUSTIN) TAE JIN HAM
General Manager
Celgene (Korean Affiliate)
JOHN HARRIS
Director
Veralon
Philadelphia, PA
TODD HERRMANN
President, Cadensuss
Lecturer, Simmons School of Business
East Sandwich, MA
34
JANE HERZECA
VP Operations
Quartet
New York, NY
CARRIE HIEBELER
Senior Investment Officer
Ventas, Inc.
Winnetka, IL
ANNE HOANG
Regional Senior Vice President, Operations,
The US Oncology Network
McKesson
San Francisco, CA
SAM HOLLIDAY
Co-Founder & COO
HEROIQ Health
New York, NY
BRIAN HOLZER, M.D.
CEO
Lacuna Health, A Kindred Healthcare
Company
Louisville, KY
YANG HU
Global Health Fellow
Bill & Melinda Gates Foundation
Seattle, WA
BOB HUANG
Investment Director
Seidler Equity Australia
Sydney, NSW, Australia
BRANDON HULL
Cardinal Partners (Retired Member)
New Mountain Capital (Industry Advisor)
Norfolk, VA
OREN K. ISACOFF
Principal
Longitude Capital
Greenwich, CT
VIVEK JAIN
Vice President
H.I.G. Capital
New York, NY
EMILY JANVEY, M.D.
Director
KKR
Menlo Park, CA
MAGGIE (HILL) JARRETT
Principal
Cedar Investors
Denver, CO
PRASHANTH JAYARAM, M.D.
Portfolio Manager
Citadel Global Equities
New York, NY
TYLER JORGENSEN
Consultant
BCG
Boston, MA
KEVIN JURKOWSKI
Director, Program Management
Abbott
Sylmar, CA
ASH KHANNA
Venture Partner
Pivotal Bio Venture Partners
San Francisco, CA
MIKE KIJEWSKI
CEO, Co-founder
MedCrypt
Solana Beach, CA
JOYCE KIM
Director, Service Line Performance
Improvement and Data Analysis
Main Line Health
Newton Square, PA
TINA KIND
Managing Partner
DTS Group
Orlando, FL
ERIC KLEIN
Vice President
Bridge Growth Partners
New York, NY
CLAYTON D. KNOX, M.D.
Chief Operating Officer
MavuPharma
Kirkland, WA
MICHAEL KOBY
Partner
1315 Capital
Philadelphia, PA
DAVE KONCIAK
VP, Business Development & Strategy
Surface Oncology
Cambridge, MA
AARON KORNETZKE
Business Development
Doximity
San Francisco, CA
SRI KOTTE
Head of Partnerships
Genome Medical
S. South Francisco, CA
MICHAEL KRAMARZ
Investment Research Analyst
Samlyn Capital, LLC
New York, NY
LISA A. LACASSE
Deputy President & SVP,
Strategy & Operations
American Cancer Society
Cancer Action Network
Washington, DC
DAVID LAMACCHIA
Principal
NaviMed Capital
Milton, GA
ELAINE LE
Corporate Development Associate
Medtronic
Shanghai, China
JENNIFER LEE
Vice President Development
Lyric Hospitality
San Francisco, CA
RICHARD LEE, M.D.
Associate Professor
Weill Cornell Medical College
New York, NY
ADAM LESSLER, M.D.
Principal
Canepa Healthcare
New York, NY
BRIAN LEWANDOWSKI
Analyst
Tamarack Capital Management
Carlsbad, CA
CHRISTINA LIAO
Senior Consultant, Clinical/Transformation
Cedars-Sinai Health System
Santa Monica, CA
YI LIAO
Senior Product Manager
Vidyo, Inc.
Sioux Falls, SD
JEFFREY S. LITWIN, M.D.
Chief Operating Officer,
Clinical Services Organization
WCG Clinical
Princeton, NJ
GABRIEL LUFT
Vice President
Amulet Capital Partners
Greenwich, CT
RENZO LUZZATTI
President
US - Rx Care
Vienna, VA
SARAH LYON
Director, Medtronic Vascular Strategy
& Portfolio Management
Medtronic
Plymouth, MN
JOSH MAGID
Associate, Healthcare
Evercore
New York, NY
JOAN MAGRUDER
President, St. Louis Children’s Hospital;
Group President, BJC HealthCare
St. Louis Children’s Hospital
St. Louis, MO
SAMIR MALIK
Founder / General Manager
Genoa Telepsychiatry (United Health Group)
New York, NY
GREGG MCCONNELL
VP
Blue Rock Therapeutics
Washington, DC
Health Care Program Mentors
35
ROBERT C. MCDONALD, M.D.
President
Aledo Consulting, Inc.
Indianapolis, IN
KAREN MEADOR, MD
Senior Physician Executive,
Managing Director
BDO
New York, NY
JEAN M. MELLETT
Associate Vice President,
Planning & Strategy
Northern Light Health
Brewer, ME
MICHAEL C. MENG
Chairman, President & CFO
Stellar Health
New York, NY
GREG MILLHAUSER
Portfolio Manager of Private Investments
The Glenmede Trust
Philadelphia, PA
GRETCHEN MILLS
Manager Strategy and Market Research
3M Health Information Systems
Murray, UT
SACHIYO MINEGISHI
VP, Lead for Sickle Cell Disease Program
bluebird bio
Cambridge, MA
MATT MOURADIAN
Chief Operating Officer
Renew.com
Santa Monica, CA
DAN MULREANY
Associate Director,
Business Development
QED Therapeutics
Sand Francisco, CA
HAREESH NAIR
Managing Director
Fosun Healthcare Holdings
Singapore
DAVID B. NASH, M.D.
Dean-College of Population Health
Jefferson College of Population Health
Philadelphia, PA
NAOKO NISHITANI
Associate Partner
ZS
Princeton, NJ
MATT NIX
Senior Mgr. Solution Engineering
Instamed
Philadelphia, PA
WESLEY NURSS
Portfolio Analyst
Marshall Wace
New York, NY
YELENA OFENGEYM
Manager
Manatt Health Strategies
New York, NY
JUSTIN PALLARI
Director
Clinton Health Access Initiative
New Delhi, India
SHAUNAK PARIKH
Principal
EW Healthcare Partners
New York, NY
JEAN PATTERSON
Senior Vice President
AoN
Boston, MA
CARY PFEFFER, M.D.
Partner
Third Rock Ventures
Boston, MA
GARY M. PHILLIPS, M.D.
President & Chief Executive Officer
OrphoMed, Inc.
Blue Bell, PA
MATTHEW PICKENS
President, West Region
Press Ganey
Palmetto Bay, FL
SALLY POBLETE
Founder and CEO
Wellthie
New York, NY
DARSHAN PRABHU
Managing Director
Starr Investment Holdings
New York, NY
JON MICHAEL REESE
Vice President
General Atlantic
New York, NY
BOWIE REMALEY
Vice-President, Operations
Radiology Partners
El Segundo, CA
JAMES RHODES
Vice President,
Strategy and Business Development
Children’s Health System of Texas
Dallas, TX
JAMES (JAMIE) RICHTER
VP, Business Development
ReMed
Paoli, PA
PAMELA RODMAN
Director, Finance and Administration
Columbia University
New York, NY
BEN ROOKS
Managing Director
ST Advisors, Inc.
San Francisco, CA
ALEX ROSEN
Investor
Venrock
New York, NY
CRAIG E. SAMITT, M.D.
President & CEO
Blue Cross Blue Shield of Minnesota
Eagan, MN
MATT SCHULZ
Vice President
The Vistria Group
Chicago, IL
DAVID M. SCHUPPAN
Partner
The Vistria Group
Chicago, IL
JOHN SCHWARZ
Vice President, Administration
Lankenau Medical Center
Main Line Health
Wynnewood, PA
REBECCA SCHWIETZ
Senior Vice President, Clinical Services
Healthfirst
New York, NY
ANKIT SHAH
Senior Director, Commercialization
SeltPoint Medical
Valencia, CA
DEEPA D. SHAH
Senior Director, Growth
Landmark Health
Hermosa Beach, CA
RAVI N. SHAH, M.D.
Medical Director
Columbia Psychiatry
Faculty Practice Organization
New York, NY
DAVID SHEEHY
COO
Sage Growth Partners, LLC
Baltimore, MD
ANDREW SHELTON
Director, Growth Strategy
Premise Health
Brentwood, TN
ED SHENKAN
CEO
Shenkan Advisors
San Francisco, CA
DAVID SILK
Global Marketing Lead,
Healthcare and Life Sciences,
Google Cloud
Google
New York, NY
DANIEL SIMON
SVP, BioPharma Business
Guardant Health
Redwood City, CA
36
BETH SOMERS STUTZMAN
Principal and Career coach
Somers Stutzman Consulting
Lexington, MA
MAUREEN A. SPIVACK
Senior Healthcare Industry Partner
New State Capital Partners
Larchmont, NY
JAMES STANFORD
Co-Founder, Managing Partner
Fitzroy Health Holdings, LLC
New York, NY
CHARLES “SCOTLAND” STEVENS
General Partner
OrbiMed Advisors LLC
New York, NY
WILL STRATTON
Manager, Corporate and Global
Business Development
Rakuten Aspyrian
San Diego, CA
MICHAEL STROUP
SVP Acquisitions
United Surgical Partners International
Dallas, TX
FERNANDO TORRES
Vice President
Kaufman Hall
Atlanta, GA
GEOFFREY TRESLEY
Vice President
GTCR
Chicago, IL
MAYA TSUKERNIK
VP, Customer Innovation
Aetion, Inc.
New York, NY
JOHN URQUHART
Partner
HealthCare Royalty Partners
Boston, MA
DANIEL VAN DEN BERGH
Investor
Kaiser Permanente Ventures
Oakland, CA
REED VAN GORDEN
Managing Director
Deerpath Capital Management
Chicago, IL
JEFF VOIGT
Principal
Medical Device Consultants
of Ridgewood LLC
Ridgewood, NJ
DAVE WALTON
CEO and Founder
Chronicare
Newtown, PA
JONATHAN WANG
SVP & Head of
Business Development
Zai Lab
Shanghai, China
CHRIS WILKERSON
President
EquipSystems, LLC
New York, NY
HELENE WOLK
SVP Operations/COO
Englewood Health
Englewood, NJ
CHIA WU, M.D.
Orthopaedic Hand Surgeon
New York Presbyterian --
Columbia University
New York, NY
AMANDA WYATT
Marketing Manager
Pfizer Inc.
New York, NY
YAN YAN, M.D.
Senior Director, Corporate Strategy
Quest Diagnostics
Secaucus, NJ
MO YANG
Vice President
GI Partners
San Francisco, CA
JON YEATMAN
Chief Strategy Officer
Mission Health
Asheville, NC
DANIEL YIP
VP, Commercial Operations
Intercept Pharmaceuticals
New York, NY
BRANDI (HERMAN) YODER
Sr. Finance Director
Johnson & Johnson (Ethicon)
Cincinnati, OH
DEREK YUAN
Senior Director, Corporate Development
Zai Lab
Shanghai, China
THOMAS ZIPP
Head of Strategy & Brand Development
Vygen
Exton, PA
Health Care Program Mentors
37
GEOFFREY M. GARRETT, PH.D.
Dean,
The Wharton School
HOWARD KAUFOLD, PH.D.
Vice Dean and Director,
The Wharton Graduate Division
SCOTT E. HARRINGTON, PH.D.
Chair,
Health Care Management Department, The Wharton School;
Director,
MBA Program in Health Care Management
JUNE M. KINNEY, M.A.
Associate Director,
MBA Program in Health Care Management
CAROLINE SAVOIE
Administrative Coordinator,
MBA Program in Health Care Management
JANICE SINGLETON
Administrative Coordinator,
MBA Program in Health Care Management
Administration
38
The Program Faculty are drawn from
the Wharton School, the School of
Medicine, the School of Nursing, and
the School of Arts and Sciences at the
University of Pennsylvania and leading
health institutions in Philadelphia.
Additional support is provided by the
Fellows and Associates of the Leonard
Davis Institute of Health Economics.
ABBY E. ALPERT, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
EUGENIO ANESSI, PH.D.
Professor, Public Management,
Bocconi University Graduate School
of Management, Milan, Italy;
Lecturer and Senior Fellow,
Health Care Management,
The Wharton School
DAVID A. ASCH, M.D., M.B.A.
Executive Director,
Penn Medicine Center for Health
Care Innovation;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
THOMAS E. BAKER, J.D.
William Maul Measey Professor of
Law and Health Sciences, University
of Pennsylvania Law School;
Professor of Health Care Management,
The Wharton School
LAWTON R. BURNS, PH.D., M.B.A.
James Joo-Jin Kim Professor of Health
Care Management, The Wharton School;
Faculty Co-Director,
Roy and Diana Vagelos Program
In Life Sciences & Management
PATRICIA M. DANZON, PH.D.
Celia Z. Moh Professor Emeritus
of Health Care Management,
The Wharton School
GUY DAVID, PH.D.
Gilbert and Shelley Harrison
Associate Professor,
Health Care Management,
The Wharton School
BENJAMIN DORANZ, PH.D., M.B.A.
President and CEO, Integral Molecular
Senior Fellow, Health Care
Management, The Wharton School
EZEKIEL J. EMANUEL, M.D., PH.D.
Diane v.S. Levy and Robert M.
Levy University Professor and
Vice Provost for Global Initiatives;
Professor, Health Care Management,
The Wharton School
BRADLEY M. FLUEGEL
Senior VP & Chief Strategy
Officer, Walgreens;
Lecturer, Health Care Management,
The Wharton School
THOMAS N. GILMORE, M.ARCH.
Vice President,
The Center for Applied Research Inc.;
Senior Fellow, Health Care Management,
The Wharton School
JOHN P. GLASER, PH.D.
Senior Vice President, Client
Administration, Cerner Corporation;
Lecturer, Health Care Management
The Wharton School
HENRY A. GLICK, PH.D.
Professor of Medicine,
Perelman School of Medicine at
the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
MATTHEW R. GRENNAN, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
ATUL GUPTA, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
SCOTT E. HARRINGTON, PH.D.
Chair, Health Care Management
Department, and Director,
Health Care Management Program,
The Wharton School
Alan B. Miller Professor of Health Care
Management and Business Economics
and Public Policy, The Wharton School
ERIC M. HEIL
SVP, Chief Commercial Officer
Software Solutions, NaviHealth, Inc.;
Lecturer, Health Care Management,
The Wharton School
JOHN C. HERSHEY, PH.D.
Anheuser-Busch Professor Emeritus
of Management Science; and
Health Care Management,
The Wharton School
JOHN KIMBERLY, PH.D.
Henry Bower Professor Emeritus, Health
Care Management, The Wharton School
JUNE M. KINNEY, M.A.
Associate Director, Graduate Program
in Health Care Management;
Lecturer, Health Care Management,
The Wharton School
GARY J. KURTZMAN, M.D.
Vice President, Life Sciences,
Safeguard Scientifics; Lecturer,
Health Care Management,
The Wharton School
RISA LAVIZZO-MOUREY, M.D., M.B.A
PIK Professor of Population Health
and Health Equity
Perelman School of Medicine, School
of Nursing and The Wharton School
University of Pennsylvania
CLAUDIO LUCARELLI, PH.D.
Associate Professor,
Health Care Management,
The Wharton School
JEFFREY P. LIBSON, J.D.
Partner, Cooley;
Lecturer, Health Care Management,
The Wharton School
HARI MAHADEVAN, PH.D.
Independent Consultant;
Lecturer and Senior Fellow,
Health Care Management,
The Wharton School
INGRID NEMBHARD, PH.D., M.S.
Fishman Family President’s
Distinguished Associate Professor,
Health Care Management,
The Wharton School
STEVEN A. NICHTBERGER, M.D.
Adjunct Professor and Senior Fellow,
Health Care Management,
The Wharton School
MITESH S. PATEL, M.D.
Assistant Professor of Medicine, Perelman
School of Medicine at the University
of Pennsylvania School of Medicine;
Assistant Professor of Health Care
Management, The Wharton School
MARK V. PAULY, PH.D.
John M. and Thomas L. Bendheim
Professor; Professor, Health Care
Management, Business Economics and
Public Policy, The Wharton School;
Professor, Economics, College of Arts
and Sciences
WILLIAM P. PIERSKALLA, PH.D.
Professor Emeritus
Faculty
39
DANIEL POLSKY, PH.D.
Robert D. Eilers Professor of Health Care
Management and Economics,
The Wharton School;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Executive Director, Leonard Davis
Institute of Health Economics
DOUGLAS A. PRESENT, M.B.A.
Investor and Advisor;
Lecturer, Health Care Management,
The Wharton School
ARNOLD J. ROSOFF, J.D.
Professor Emeritus,
Legal Studies and Business Ethics;
Lecturer, Health Care Management,
The Wharton School
STEPHEN M. SAMMUT
Lecturer and Senior Fellow,
Health Care Management,
Lecturer, Entrepreneurial Programs,
The Wharton School
CYNTHIA SCALZI, M.N., PH.D.
Professor Emeritus of Nursing
and Health Care Management,
The Wharton School
J. SANFORD SCHWARTZ, M.D.
Leon Hess Professor in Internal
Medicine, Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
JEFFREY H. SILBER, M.D., PH.D.
Director, Center for Outcomes Research,
The Children’s Hospital of Philadelphia;
Professor of Pediatrics and
Anesthesiology & Critical Care,
Perelman School of Medicine at
the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
JEFFREY A. SOLOMON, M.D., M.B.A.
Founding Partner, Infiniti Medical LLC;
Lecturer, Health Care Management,
The Wharton School
ASHLEY SWANSON, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
KEVIN G.M. VOLPP, M.D., PH.D.
Director, Center for Health Incentives
and Behavioral Economics,
Leonard Davis Institute;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
SCOTT E. HARRINGTON, PH.D.
Director,
MBA Program in
Health Care Management,
The Wharton School
JUNE KINNEY
Associate Director, MBA Program
in Health Care Management
The Wharton School
The University of Pennsylvania
values diversity and seeks talented
students, faculty and staff from diverse
backgrounds. The University of
Pennsylvania does not discriminate
on the basis of race, sex, sexual
orientation, gender identity, religion,
color, national or ethnic origin, age,
disability, or status as a Vietnam Era
Veteran or disabled veteran in the
administration of educational policies,
programs or activities; admissions
policies; scholarship and loan awards;
athletic, or other University adminis-
tered programs or employment.
Questions or complaints regarding
this policy should be directed to:
Executive Director,
Office of Affirmative Action
and Equal Opportunity Programs
Sansom Place East
3600 Chestnut Street, Suite 228
Philadelphia, PA 19104-6106
215.898.6993 (Voice)
215.898.7803 (TDD)
©2019, The Trustees of
the University of Pennsylvania.
All rights reserved.
Photography of students: adamgierkephotography.com
RACHEL M. WERNER, M.D., PH.D
Associate Professor of Medicine,
Perelman School of Medicine at the
University of Pennsylvania School of
Medicine; Associate Professor and Senior
Fellow, Operations and Information
Management, Health Care Management,
The Wharton School
JOHN J. WHITMAN, M.B.A.
Executive Director, The TRECS Institute;
Lecturer, Health Care Management,
The Wharton School
SANKEY V. WILLIAMS, M.D.
Professor of General
Internal Medicine; Professor,
Health Care Management,
The Wharton School
